• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Nutrien Reports Third Quarter 2025 Results

    11/5/25 5:00:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials
    Get the next $NTR alert in real time by email
    • Nine-month results supported by strong operational performance and continue to show progress towards our 2026 targets.



    • Initiating a review of strategic alternatives for our Phosphate business to enhance long-term value.

    All amounts are in US dollars, except as otherwise noted

    Nutrien Ltd. (TSX and NYSE:NTR) announced today its third quarter 2025 results, with net earnings of $0.5 billion ($0.96 diluted net earnings per share). Third quarter 2025 adjusted EBITDA1 was $1.4 billion and adjusted net earnings per share1 was $0.97.

    "Nutrien delivered structural earnings growth in the first nine months of 2025 through record upstream fertilizer sales volumes, improved reliability and higher Retail earnings, while lowering capital expenditures and increasing cash returned to shareholders. We continue to progress our strategic initiatives and take actions to simplify our portfolio, enhancing earnings quality, improving cash conversion and supporting growth in free cash flow per share over the long term," commented Ken Seitz, Nutrien's President and CEO.

    "The outlook for our business is supported by expectations for healthy crop input demand and growth in global potash shipments in 2026. Our focus remains on utilizing our world-class asset base to efficiently supply our customers with the products and services they need," added Mr. Seitz.

    Highlights2:

    • Generated net earnings of $1.7 billion and adjusted EBITDA of $4.8 billion in the first nine months of 2025. Adjusted EBITDA increased due to higher fertilizer net selling prices, increased upstream fertilizer sales volumes and higher Retail earnings.
    • Retail adjusted EBITDA increased to $1.4 billion in the first nine months of 2025 due to lower operating expenses from our cost savings initiatives and higher proprietary products gross margin.
    • Potash adjusted EBITDA increased to $1.8 billion in the first nine months of 2025 due to higher net selling prices and record sales volumes, supported by strong potash affordability and underlying consumption growth in key offshore markets.
    • Nitrogen adjusted EBITDA increased to $1.6 billion in the first nine months of 2025 due to higher net selling prices and sales volumes. Our operations delivered a record ammonia operating rate3 of 94 percent in the first nine months of 2025, achieved through improved reliability at our sites.
    • Returned $1.2 billion to shareholders in the first nine months of 2025 through dividends and share repurchases. We repurchased 8.3 million shares in 2025 for a total of $465 million, as of November 4, 2025.
     

    1 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section. All references to per share amounts pertain to diluted net earnings per share, unless otherwise noted.

    2 Our discussion of highlights set out on this page is a comparison of the results for the nine months ended September 30, 2025 to the results for the nine months ended September 30, 2024, unless otherwise noted.

    3 Excludes Trinidad and Joffre.

    Strategic Actions:

    We are taking actions to simplify our portfolio and focus on core assets to enhance earnings quality and free cash flow.

    • We are initiating a review of strategic alternatives for our Phosphate business, which could include reconfiguring operations, strategic partnerships or a potential sale. We intend to solidify the optimal path for our Phosphate business in 2026.



    • On October 23, 2025, we completed a controlled shut down of our Trinidad Nitrogen facility due to uncertainty with respect to port access and a lack of reliable and economic gas supply that has reduced the free cash flow contribution of the Trinidad Nitrogen operations over an extended period of time. We continue to engage with stakeholders and assess options to enhance the long-term financial performance of our Trinidad operations.



    • On September 8, 2025, we announced an agreement to sell our 50 percent equity interest in Profertil S.A. for approximately $0.6 billion, increasing expected gross proceeds from asset divestitures to approximately $0.9 billion over the last twelve months. We intend to allocate the sale proceeds to initiatives consistent with our capital allocation priorities, including targeted growth investments, share repurchases and debt reduction.





    Management's Discussion and Analysis

    The following management's discussion and analysis ("MD&A") is the responsibility of management and is dated as of November 5, 2025. The Board of Directors ("Board") of Nutrien carries out its responsibility for review of this disclosure principally through its Audit Committee, composed entirely of independent directors. The Audit Committee reviews and, prior to its publication, approves this disclosure pursuant to the authority delegated to it by the Board. The term "Nutrien" refers to Nutrien Ltd. and the terms "we", "us", "our", "Nutrien" and "the Company" refer to Nutrien and, as applicable, Nutrien and its direct and indirect subsidiaries on a consolidated basis. Additional information relating to Nutrien (which, except as otherwise noted, is not incorporated by reference herein), including our annual report dated February 20, 2025 ("2024 Annual Report"), which includes our annual audited consolidated financial statements ("annual financial statements") and MD&A, and our annual information form dated February 20, 2025, each for the year ended December 31, 2024, can be found on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. No update is provided to the disclosure in our 2024 annual MD&A except for material information since the date of our annual MD&A. The Company is a foreign private issuer under the rules and regulations of the US Securities and Exchange Commission (the "SEC").

    This MD&A is based on, and should be read in conjunction with, the Company's unaudited interim condensed consolidated financial statements as at and for the three and nine months ended September 30, 2025 ("interim financial statements") based on International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board and prepared in accordance with International Accounting Standard ("IAS") 34 "Interim Financial Reporting", unless otherwise noted. This MD&A contains certain non-GAAP financial measures and ratios and forward-looking statements, which are described in the "Non-GAAP Financial Measures" and the "Forward-Looking Statements" sections, respectively.





    Market Outlook and Guidance

    Agriculture and Retail Markets

    • Record crop production prospects in the US and trade uncertainties pressured crop prices; however, recently reported trade agreements between the US and China and proposed government payments are expected to provide support to farmers. The need to replenish crop nutrients removed from a record crop is expected to drive healthy crop nutrient demand ahead of the next planting season.
    • Brazilian soybean acreage is expected to increase by two to four percent in 2025 supported by a faster than average planting pace and strong international demand. Safrinha corn acreage is expected to increase by a similar amount, further supporting crop input demand.
    • Crop production prospects in most regions of Australia have improved following timely rainfall and recent strength in livestock markets is expected to further support farmer returns.

    Crop Nutrient Markets

    • We maintained our 2025 global potash shipment forecast of 73 to 75 million tonnes, reflecting the upward revision made last quarter. We expect continued global potash demand growth and forecast global potash shipments between 74 and 77 million tonnes in 2026 supported by favorable affordability and low projected channel inventories in major markets. We anticipate limited new global capacity additions in 2026 with announced project delays.
    • We expect 2 percent growth in global nitrogen demand in 2025 and supply related challenges to maintain a tight supply and demand balance going into 2026. Global ammonia markets are expected to remain tight due to plant outages and project delays. We anticipate the pace of Chinese urea exports will slow in the fourth quarter of 2025 and the emergence of seasonal demand to support market fundamentals.
    • Phosphate markets continue to be tight due to limited supply, including from Chinese export restrictions. Global shipments in 2025 have been constrained by supply availability and weaker affordability for phosphate fertilizer has impacted demand.

    Financial and Operational Guidance

    • Retail adjusted EBITDA guidance of $1.68 to $1.82 billion assumes higher crop nutrient and crop protection sales in the second half of 2025 compared to 2024 and continued recovery in Brazil, consistent with our previous expectations.
    • Potash sales volume guidance was increased to 14.0 to 14.5 million tonnes due to the continued strength of global demand. The range is consistent with our historical share of global shipments.
    • Nitrogen sales volume guidance of 10.7 to 11.0 million tonnes assumes no additional sales volumes from our Trinidad operations for the remainder of 2025, partially offset by the continued strong performance of our North American nitrogen operations.
    • Phosphate sales volume guidance of 2.35 to 2.55 million tonnes assumes improved operating rates and sales volumes in the fourth quarter of 2025 compared to the prior year.
    • Total capital expenditures of $2.0 to $2.1 billion includes approximately $400 to $500 million in investing capital expenditures focused on proprietary products, network optimization and digital capabilities in Retail, low-cost brownfield expansions in Nitrogen and mine automation projects in Potash.

    All guidance numbers, including those noted above, are outlined in the table below. Refer to page 58 of our 2024 Annual Report for anticipated fertilizer pricing and natural gas price sensitivities relating to adjusted EBITDA (consolidated) and adjusted net earnings per share.

     

    2025 Guidance Ranges 1 as of

     

    November 5, 2025

     

    August 6, 2025

    ($ billions, except as otherwise noted)

    Low

     

    High

     

    Low

     

    High

    Retail adjusted EBITDA

    1.68

     

    1.82

     

    1.65

     

    1.85

    Potash sales volumes (million tonnes) 2

    14.0

     

    14.5

     

    13.9

     

    14.5

    Nitrogen sales volumes (million tonnes) 2

    10.7

     

    11.0

     

    10.7

     

    11.2

    Phosphate sales volumes (million tonnes) 2

    2.35

     

    2.55

     

    2.35

     

    2.55

    Depreciation and amortization

    2.35

     

    2.40

     

    2.35

     

    2.45

    Finance costs

    0.65

     

    0.70

     

    0.65

     

    0.75

    Effective tax rate on adjusted net earnings (%) 3

    24.5

     

    25.5

     

    24.0

     

    26.0

    Capital expenditures 4

    2.0

     

    2.1

     

    2.0

     

    2.1

    1 See the "Forward-Looking Statements" section.

    2 Manufactured product only.

    3 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section.

    4 Comprised of sustaining capital expenditures, investing capital expenditures and mine development and pre-stripping capital expenditures, which are supplementary financial measures. See the "Other Financial Measures" section.

    Consolidated Results

     

    Three Months Ended September 30

     

    Nine Months Ended September 30

    ($ millions, except as otherwise noted)

    2025

     

    2024

     

    % Change

     

    2025

     

    2024

     

    % Change

    Sales

    6,007

     

    5,348

     

    12

     

    21,545

     

    20,893

     

    3

    Gross margin

    1,964

     

    1,500

     

    31

     

    6,459

     

    5,949

     

    9

    Expenses

    1,157

     

    1,304

     

    (11)

     

    3,644

     

    4,490

     

    (19)

    Net earnings

    469

     

    25

     

    n/m

     

    1,717

     

    582

     

    195

    Adjusted EBITDA 1

    1,431

     

    1,010

     

    42

     

    4,769

     

    4,300

     

    11

    Diluted net earnings per share (dollars) 2

    0.96

     

    0.04

     

    n/m

     

    3.48

     

    1.13

     

    208

    Adjusted net earnings per share (dollars) 1, 2

    0.97

     

    0.39

     

    149

     

    3.72

     

    3.18

     

    17

    1 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section.

    2 All references to per share amounts pertain to diluted net earnings per share, unless otherwise noted.

    Net earnings and adjusted EBITDA increased in the third quarter and first nine months of 2025 compared to the same periods in 2024 primarily due to higher fertilizer net selling prices, increased upstream fertilizer sales volumes and higher Retail earnings. Net earnings in the third quarter of 2024 were impacted by higher expense for asset retirement obligations at non-operating sites.





    Segment Results

    Our discussion of segment results set out on the following pages is a comparison of the results for the three and nine months ended September 30, 2025 to the results for the three and nine months ended September 30, 2024, unless otherwise noted.

    Nutrien Ag Solutions ("Retail")

     

    Three Months Ended September 30

     

    Nine Months Ended September 30

    ($ millions, except as otherwise noted)

    2025

     

    2024

     

    % Change

     

    2025

     

    2024

     

    % Change

    Sales

    3,427

     

    3,271

     

    5

     

    14,476

     

    14,653

     

    (1)

    Cost of goods sold

    2,505

     

    2,412

     

    4

     

    10,850

     

    11,018

     

    (2)

    Gross margin

    922

     

    859

     

    7

     

    3,626

     

    3,635

     

    ‐

    Adjusted EBITDA 1

    230

     

    151

     

    52

     

    1,425

     

    1,356

     

    5

    1 See Note 2 to the interim financial statements.

    • Retail adjusted EBITDA increased in the third quarter and first nine months of 2025 due to lower operating expenses from our cost savings initiatives and higher proprietary products gross margin.

     

    Three Months Ended September 30

     

    Nine Months Ended September 30

     

    Sales

     

    Gross Margin

     

    Sales

     

    Gross Margin

    ($ millions)

    2025

     

    2024

     

    2025

     

    2024

     

    2025

     

    2024

     

    2025

     

    2024

    Crop nutrients

    1,188

     

    1,093

     

    220

     

    210

     

    5,773

     

    5,683

     

    1,136

     

    1,150

    Crop protection products

    1,536

     

    1,518

     

    399

     

    360

     

    5,174

     

    5,365

     

    1,266

     

    1,271

    Seed

    156

     

    132

     

    24

     

    24

     

    1,966

     

    2,051

     

    360

     

    379

    Services and other

    258

     

    242

     

    178

     

    164

     

    690

     

    690

     

    531

     

    528

    Merchandise

    222

     

    222

     

    34

     

    37

     

    649

     

    667

     

    109

     

    110

    Nutrien Financial

    89

     

    85

     

    89

     

    85

     

    294

     

    284

     

    294

     

    284

    Nutrien Financial elimination 1

    (22)

     

    (21)

     

    (22)

     

    (21)

     

    (70)

     

    (87)

     

    (70)

     

    (87)

    Total

    3,427

     

    3,271

     

    922

     

    859

     

    14,476

     

    14,653

     

    3,626

     

    3,635

    1 Represents elimination of the interest and service fees charged by Nutrien Financial to Retail branches.

    • Crop nutrients sales and gross margin increased in the third quarter of 2025 due to higher sales volumes and selling prices, which was supported by a stronger application season in North America. For the first nine months of 2025, sales increased due to higher selling prices, and gross margin was impacted by product mix shifts in North America. International crop nutrient sales volumes were lower in the third quarter and first nine months of 2025 mainly due to strategic actions in South America.
    • Crop protection products sales and gross margin were higher in the third quarter of 2025 due to a stronger plant health season in North America, paired with higher proprietary products gross margin. Sales and gross margin were lower in the first nine months of 2025 due to dry conditions in Australia in the first half of 2025 and product mix shifts in North America.
    • Seed sales increased in the third quarter of 2025 due to delayed field activity in the US that shifted sales from the second quarter of 2025. Sales and gross margin were lower in the first nine months of 2025 due to weather related impacts in the Southern US leading to fewer planted acres which impacted proprietary products gross margin.

    Supplemental Data

    Three Months Ended September 30

     

    Nine Months Ended September 30

     

    Gross Margin

     

    % of Product Line 1

     

    Gross Margin

     

    % of Product Line 1

    ($ millions, except as otherwise noted)

    2025

     

    2024

     

    2025

     

    2024

     

    2025

     

    2024

     

    2025

     

    2024

    Proprietary products

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Crop nutrients

    88

     

    71

     

    40

     

    38

     

    385

     

    361

     

    34

     

    31

    Crop protection products

    161

     

    119

     

    41

     

    32

     

    460

     

    429

     

    36

     

    34

    Seed

    15

     

    4

     

    57

     

    22

     

    130

     

    148

     

    36

     

    39

    Merchandise

    4

     

    4

     

    12

     

    11

     

    10

     

    11

     

    9

     

    10

    Total

    268

     

    198

     

    29

     

    24

     

    985

     

    949

     

    27

     

    26

    1 Represents percentage of proprietary product margins over total product line gross margin.

     

    Three Months Ended September 30

     

    Nine Months Ended September 30

     

    Sales Volumes

    (tonnes - thousands)

     

    Gross Margin / Tonne

    (dollars)

     

    Sales Volumes

    (tonnes - thousands)

     

    Gross Margin / Tonne

    (dollars)

     

    2025

     

    2024

     

    2025

     

    2024

     

    2025

     

    2024

     

    2025

     

    2024

    Crop nutrients

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    North America

    1,019

     

    931

     

    158

     

    165

     

    6,902

     

    6,693

     

    145

     

    147

    International

    834

     

    956

     

    71

     

    59

     

    2,732

     

    2,999

     

    51

     

    56

    Total

    1,853

     

    1,887

     

    119

     

    111

     

    9,634

     

    9,692

     

    118

     

    119

     

    (percentages)

    September 30, 2025

     

    December 31, 2024

    Financial performance measures 1, 2

     

     

     

    Cash operating coverage ratio

    62

     

    63

    Adjusted average working capital to sales

    21

     

    20

    Adjusted average working capital to sales excluding Nutrien Financial

    1

     

    -

    Nutrien Financial adjusted net interest margin

    5.4

     

    5.3

    1 Rolling four quarters.

    2 These are non-GAAP financial measures. See the "Non-GAAP Financial Measures" section.

    Potash

     

    Three Months Ended September 30

     

    Nine Months Ended September 30

    ($ millions, except as otherwise noted)

    2025

     

    2024

    % Change

     

    2025

     

    2024

    % Change

    Net sales

    1,122

     

    884

    27

     

    2,857

     

    2,453

    16

    Cost of goods sold

    437

     

    422

    4

     

    1,257

     

    1,139

    10

    Gross margin

    685

     

    462

    48

     

    1,600

     

    1,314

    22

    Adjusted EBITDA 1

    733

     

    555

    32

     

    1,809

     

    1,557

    16

    1 See Note 2 to the interim financial statements.

    • Potash adjusted EBITDA increased in the third quarter and first nine months of 2025 due to higher net selling prices, partially offset by higher provincial mining taxes. Total sales volumes in the first nine months of 2025 were the highest on record.

    Manufactured Product

    Three Months Ended

    September 30

     

    Nine Months Ended

    September 30

    ($ per tonne, except as otherwise noted)

    2025

     

    2024

     

    2025

     

    2024

    Sales volumes (tonnes - thousands)

     

     

     

     

     

     

     

    North America

    1,562

     

    1,733

     

    3,912

     

    3,954

    Offshore

    2,497

     

    2,419

     

    7,538

     

    7,174

    Total sales volumes

    4,059

     

    4,152

     

    11,450

     

    11,128

    Net selling price

     

     

     

     

     

     

     

    North America

    319

     

    264

     

    283

     

    287

    Offshore

    250

     

    177

     

    232

     

    183

    Average net selling price

    277

     

    213

     

    250

     

    220

    Cost of goods sold

    108

     

    102

     

    111

     

    102

    Gross margin

    169

     

    111

     

    139

     

    118

    Depreciation and amortization

    46

     

    43

     

    47

     

    43

    Gross margin excluding depreciation and amortization 1

    215

     

    154

     

    186

     

    161

    1 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section.

     
    • Sales volumes were lower in the third quarter of 2025 compared to the record period in 2024, despite strong engagement in our North American summer fill program. Offshore sales volumes in the third quarter and first nine months of 2025 were higher, supported by strong potash affordability and underlying consumption growth in key offshore markets.
    • Net selling price per tonne increased in the third quarter of 2025 due to higher global benchmark prices compared to the same period in 2024. For the first nine months of 2025, net selling price per tonne increased driven by stronger offshore benchmark prices, notably in Brazil and Southeast Asia, partially offset by lower North American benchmark prices in the first quarter of 2025.
    • Cost of goods sold per tonne increased in the third quarter and first nine months of 2025 primarily due to higher depreciation. Controllable cash cost of product manufactured per tonne increased in the first nine months of 2025 driven by lower production and higher turnaround costs.

    Supplemental Data

    Three Months Ended

    September 30

     

    Nine Months Ended

    September 30

     

    2025

     

    2024

     

    2025

     

    2024

    Production volumes (tonnes – thousands)

    3,607

     

    3,696

     

    10,427

     

    10,836

    Potash controllable cash cost of product manufactured per tonne 1

    56

     

    52

     

    57

     

    52

    Canpotex sales by market (percentage of sales volumes) 2

     

     

     

     

     

     

     

    Latin America

    47

     

    46

     

    40

     

    41

    Other Asian markets 3

    26

     

    27

     

    30

     

    29

    China

    8

     

    9

     

    11

     

    12

    India

    6

     

    4

     

    4

     

    5

    Other markets

    13

     

    14

     

    15

     

    13

    Total

    100

     

    100

     

    100

     

    100

    1 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section.

    2 See Note 9 to the interim financial statements.

    3 All Asian markets except China and India.

    Nitrogen

     

    Three Months Ended September 30

     

    Nine Months Ended September 30

    ($ millions, except as otherwise noted)

    2025

     

    2024

    % Change

     

    2025

     

    2024

    % Change

    Net sales

    1,063

     

    793

    34

     

    3,277

     

    2,732

    20

    Cost of goods sold

    666

     

    581

    15

     

    2,073

     

    1,835

    13

    Gross margin

    397

     

    212

    87

     

    1,204

     

    897

    34

    Adjusted EBITDA 1

    556

     

    355

    57

     

    1,631

     

    1,413

    15

    1 See Note 2 to the interim financial statements.

    • Nitrogen adjusted EBITDA increased in the third quarter and first nine months of 2025 due to higher net selling prices and higher sales volumes, which more than offset higher natural gas costs and lower equity earnings from Profertil S.A. ("Profertil"). Adjusted EBITDA for the first nine months of 2024 benefited from insurance recoveries. Our operations delivered a record ammonia operating rate of 94 percent in the first nine months of 2025, achieved through improved reliability at our sites.

    Manufactured Product

    Three Months Ended

    September 30

     

    Nine Months Ended

    September 30

    ($ per tonne, except as otherwise noted)

    2025

     

    2024

     

    2025

     

    2024

    Sales volumes (tonnes - thousands)

     

     

     

     

     

     

     

    Ammonia

    644

     

    567

     

    1,874

     

    1,782

    Urea and ESN®

    687

     

    661

     

    2,443

     

    2,300

    Solutions, nitrates and sulfates

    1,496

     

    1,227

     

    3,996

     

    3,698

    Total sales volumes

    2,827

     

    2,455

     

    8,313

     

    7,780

    Net selling price

     

     

     

     

     

     

     

    Ammonia

    400

     

    375

     

    408

     

    395

    Urea and ESN®

    507

     

    400

     

    485

     

    427

    Solutions, nitrates and sulfates

    272

     

    207

     

    266

     

    224

    Average net selling price

    357

     

    298

     

    362

     

    323

    Cost of goods sold

    218

     

    215

     

    220

     

    210

    Gross margin

    139

     

    83

     

    142

     

    113

    Depreciation and amortization

    56

     

    54

     

    56

     

    54

    Gross margin excluding depreciation and amortization 1

    195

     

    137

     

    198

     

    167

    1 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section.

     
    • Sales volumes increased in the third quarter and first nine months of 2025 due to strong demand and increased production of ammonia and upgraded nitrogen products.
    • Net selling price per tonne was higher in the third quarter and first nine months of 2025 for all major nitrogen products due to stronger benchmark prices.
    • Cost of goods sold per tonne increased in the third quarter and first nine months of 2025 due to higher natural gas costs, driven by a higher Henry Hub benchmark.

    Supplemental Data

    Three Months Ended

    September 30

     

    Nine Months Ended

    September 30

     

    2025

     

    2024

     

    2025

     

    2024

    Sales volumes (tonnes – thousands)

     

     

     

     

     

     

     

    Fertilizer

    1,646

     

    1,319

     

    4,880

     

    4,458

    Industrial and feed

    1,181

     

    1,136

     

    3,433

     

    3,322

    Production volumes (tonnes – thousands)

     

     

     

     

     

     

     

    Ammonia production – total 1

    1,436

     

    1,322

     

    4,514

     

    4,157

    Ammonia production – adjusted 1, 2

    967

     

    895

     

    3,131

     

    2,912

    Ammonia operating rate (%) 2

    86

     

    79

     

    94

     

    87

    Natural gas costs (dollars per MMBtu)

     

     

     

     

     

     

     

    Overall natural gas cost excluding realized derivative impact

    3.54

     

    3.13

     

    3.59

     

    2.98

    Realized derivative impact 3

    ‐

     

    0.15

     

    ‐

     

    0.09

    Overall natural gas cost

    3.54

     

    3.28

     

    3.59

     

    3.07

    1 All figures are provided on a gross production basis in thousands of product tonnes.

    2 Excludes Trinidad and Joffre.

    3 Includes realized derivative impacts recorded as part of cost of goods sold or other income and expenses. Refer to Note 3 to the interim financial statements.

    Phosphate

     

    Three Months Ended September 30

     

    Nine Months Ended September 30

    ($ millions, except as otherwise noted)

    2025

     

    2024

    % Change

     

    2025

     

    2024

    % Change

    Net sales

    495

     

    412

    20

     

    1,251

     

    1,243

    1

    Cost of goods sold

    436

     

    383

    14

     

    1,160

     

    1,116

    4

    Gross margin

    59

     

    29

    103

     

    91

     

    127

    (28)

    Adjusted EBITDA 1

    122

     

    89

    37

     

    275

     

    298

    (8)

    1 See Note 2 to the interim financial statements.

    • Phosphate adjusted EBITDA increased in the third quarter of 2025 due to higher net selling prices and sales volumes, partially offset by higher sulfur input costs. Adjusted EBITDA decreased in the first nine months of 2025 due to higher sulfur input costs and lower sales volumes, which more than offset higher net selling prices.

    Manufactured Product

    Three Months Ended

    September 30

     

    Nine Months Ended

    September 30

    ($ per tonne, except as otherwise noted)

    2025

     

    2024

     

    2025

     

    2024

    Sales volumes (tonnes - thousands)

     

     

     

     

     

     

     

    Fertilizer

    472

     

    454

     

    1,178

     

    1,316

    Industrial and feed

    194

     

    168

     

    531

     

    510

    Total sales volumes

    666

     

    622

     

    1,709

     

    1,826

    Net selling price

     

     

     

     

     

     

     

    Fertilizer

    701

     

    605

     

    677

     

    611

    Industrial and feed

    824

     

    797

     

    821

     

    826

    Average net selling price

    737

     

    657

     

    722

     

    671

    Cost of goods sold

    643

     

    601

     

    661

     

    594

    Gross margin

    94

     

    56

     

    61

     

    77

    Depreciation and amortization

    108

     

    121

     

    124

     

    117

    Gross margin excluding depreciation and amortization 1

    202

     

    177

     

    185

     

    194

    1 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section.

     
    • Sales volumes were higher in the third quarter of 2025 mainly due to higher production volumes compared to 2024, which was impacted by weather-related events, and strong demand for purified phosphoric acid. Sales volumes were lower in the first nine months of 2025 due to lower production volumes in the first quarter.
    • Net selling price per tonne increased in the third quarter and first nine months of 2025 due to the strength of fertilizer benchmark prices. Industrial net selling prices were lower in the first nine months of 2025, reflecting the typical lag between price realizations and benchmark movements, partially offset by optimization of product mix.
    • Cost of goods sold per tonne increased in the third quarter and first nine months of 2025 primarily due to increased sulfur input costs and the impact of lower production volumes in the first nine months of 2025.

    Supplemental Data

    Three Months Ended

    September 30

     

    Nine Months Ended

    September 30

     

    2025

     

    2024

     

    2025

     

    2024

    Production volumes (P2O5 tonnes – thousands)

    378

     

    330

     

    993

     

    1,008

    P2O5 operating rate (%)

    88

     

    77

     

    78

     

    79

     

    Corporate and Others and Eliminations

     

    Three Months Ended September 30

     

    Nine Months Ended September 30

    ($ millions, except as otherwise noted)

    2025

     

    2024

     

    % Change

     

    2025

     

    2024

     

    % Change

    Corporate and Others

     

     

     

     

     

     

     

     

     

     

     

    Gross margin 1

    1

     

    ‐

     

    n/m

     

    12

     

    ‐

     

    n/m

    Selling expenses (recovery)

    (2)

     

    (2)

     

    ‐

     

    (7)

     

    (7)

     

    ‐

    General and administrative expenses

    91

     

    90

     

    1

     

    284

     

    277

     

    3

    Share-based compensation expense

    28

     

    1

     

    n/m

     

    119

     

    17

     

    600

    Foreign exchange (gain) loss, net of related derivatives

    (11)

     

    31

     

    n/m

     

    18

     

    359

     

    (95)

    Other expenses

    32

     

    194

     

    (84)

     

    96

     

    274

     

    (65)

    Adjusted EBITDA 1

    (114)

     

    (74)

     

    54

     

    (299)

     

    (296)

     

    1

    Eliminations

     

     

     

     

     

     

     

     

     

     

     

    Gross margin

    (100)

     

    (62)

     

    61

     

    (74)

     

    (24)

     

    208

    Adjusted EBITDA 1

    (96)

     

    (66)

     

    45

     

    (72)

     

    (28)

     

    157

    1 See Note 2 to the interim financial statements.

     
    • Share-based compensation expense was higher in the third quarter and first nine months of 2025 due to an increase in the fair value of our share-based awards. The fair value of our share-based awards takes into consideration several factors, such as our share price movement, our performance relative to our peer group and our return on invested capital.
    • Foreign exchange loss, net of related derivatives was lower in the first nine months of 2025 due to a lower loss on foreign currency derivatives in Brazil and lower foreign exchange losses primarily from our South American Retail region.
    • Other expenses were lower in the third quarter and first nine months of 2025 as the comparable periods of 2024 included a higher expense for asset retirement obligations related to changes in closure cost estimates at certain non-operating sites.
    • Eliminations of gross margin between operating segments increased in the third quarter and first nine months of 2025 due to higher average margins.





    Finance Costs, Income Taxes and Other Comprehensive (Loss) Income

     

    Three Months Ended September 30

     

    Nine Months Ended September 30

    ($ millions, except as otherwise noted)

    2025

     

    2024

     

    % Change

     

    2025

     

    2024

     

    % Change

    Finance costs

    170

     

    184

     

    (8)

     

    504

     

    525

     

    (4)

    Income taxes

     

     

     

     

     

     

     

     

     

     

     

    Income tax expense (recovery)

    168

     

    (13)

     

    n/m

     

    594

     

    352

     

    69

    Actual effective tax rate including discrete items (%)

    26

     

    (112)

     

    n/m

     

    26

     

    38

     

    (32)

    Other comprehensive (loss) income

    (18)

     

    122

     

    n/m

     

    191

     

    64

     

    198

     
    • Income tax expense increased in the third quarter and first nine months of 2025 mainly due to higher earnings. The effective tax rate in the third quarter of 2025 increased as the comparable period in 2024 had a tax recovery. The lower effective tax rate in the first nine months of 2025 was due to lower losses in South America.
    • Other comprehensive (loss) income was primarily driven by changes in the currency translation of our foreign operations. In the third quarter of 2025, the loss was mainly due to the depreciation of the Canadian currency, relative to the US dollar, compared to income for the same period in 2024. In the first nine months of 2025 higher income was due to the appreciation of the Brazilian, Australian and Canadian currencies, relative to the US dollar, compared to lower income for the same period in 2024.





    Liquidity and Capital Resources

    Sources and uses of liquidity

    We continued to manage our capital in accordance with our capital allocation strategy. We believe that our internally generated cash flow, supplemented by available borrowings under new or existing financing sources, if necessary, will be sufficient to meet our anticipated capital expenditures, planned growth and development activities, and other cash requirements for the foreseeable future. Refer to the "Capital Structure and Management" section for details on our existing long-term debt and credit facilities.

    Sources and uses of cash

    ($ millions, except as otherwise

    Three Months Ended September 30

     

    Nine Months Ended September 30

    noted)

    2025

     

    2024

     

    % Change

     

    2025

     

    2024

     

    % Change

    Cash (used in) provided by operating activities

    (426)

     

    (908)

     

    (53)

     

    1,030

     

    412

     

    150

    Cash used in investing activities

    (383)

     

    (506)

     

    (24)

     

    (1,121)

     

    (1,614)

     

    (31)

    Cash provided by (used in) financing activities

    51

     

    922

     

    (94)

     

    (156)

     

    786

     

    n/m

    Cash used for dividends and share repurchases 1

    (413)

     

    (318)

     

    30

     

    (1,199)

     

    (845)

     

    42

    1 This is a supplementary financial measure. See the "Other Financial Measures" section.

     

    Cash (used in) provided by operating activities

    • Cash (used in) provided by operating activities in the third quarter and first nine months of 2025 was higher compared to the same periods in 2024 due to higher fertilizer net selling prices, increased upstream fertilizer sales volumes and higher Retail earnings.

    Cash used in investing activities

    • Cash used in investing activities was lower in the third quarter and first nine months of 2025 due to a deposit received for the sale of our investment in Profertil. The first nine months of 2025 also had lower capital expenditures and included proceeds from the sale of our investment in Sinofert Holdings Limited ("Sinofert").

    Cash provided by (used in) financing activities

    • Cash provided by financing activities was lower in the third quarter of 2025 compared to the same period in 2024 due to lower commercial paper issuances.
    • Cash used in financing activities was higher in the first nine months of 2025 compared to the cash provided by financing activities in the same period in 2024 due to higher debt repayment and share repurchases.

    Cash used for dividends and share repurchases

    • Cash used for dividends and share repurchases was higher in the third quarter and first nine months of 2025 as noted in cash provided by (used in) financing activities.
     
     

    Financial Condition Review

    The following is a comparison of balance sheet categories that are considered material:

     

    As at

     

     

     

     

    ($ millions, except as otherwise noted)

    September 30, 2025

     

    December 31, 2024

     

    $ Change

     

    % Change

    Assets

     

     

     

     

     

     

     

    Cash and cash equivalents

    624

     

    853

     

    (229)

     

    (27)

    Receivables

    7,687

     

    5,390

     

    2,297

     

    43

    Inventories

    5,281

     

    6,148

     

    (867)

     

    (14)

    Prepaid expenses and other current assets

    598

     

    1,401

     

    (803)

     

    (57)

    Assets held for sale

    284

     

    ‐

     

    284

     

    ‐

    Property, plant and equipment

    22,480

     

    22,604

     

    (124)

     

    (1)

    Investments

    142

     

    698

     

    (556)

     

    (80)

    Liabilities and Shareholders' Equity

     

     

     

     

     

     

     

    Short-term debt

    2,486

     

    1,534

     

    952

     

    62

    Payables and accrued charges

    6,899

     

    9,118

     

    (2,219)

     

    (24)

    Long-term debt, including current portion

    10,390

     

    9,918

     

    472

     

    5

    Retained earnings

    11,839

     

    11,106

     

    733

     

    7

     
    • Explanations for changes in Cash and cash equivalents are in the "Liquidity and Capital Resources - Sources and uses of cash" section.
    • Receivables increased due to the seasonality of Retail sales, along with higher Potash and Nitrogen sales volumes and net selling prices.
    • Inventories decreased due to the seasonality of our Retail segment. Our North American inventory levels generally increase at year-end in preparation for the following year's planting and application seasons and drawdown from the first to third quarters.
    • Prepaid expenses and other current assets decreased due to the seasonal drawdown of prepaid inventory where Retail takes delivery of prepaid inventories throughout the planting and application seasons in North America.
    • Assets held for sale increased due to the reclassification of our investment in Profertil as an asset held for sale, pending its disposition.
    • Property, plant and equipment decreased due to depreciation offsetting capital expenditures.
    • Investments decreased due to the disposal of our remaining investment in Sinofert, dividends received from Profertil and the reclassification of our investment in Profertil to assets held for sale.
    • Short-term debt increased due to seasonal working capital requirements and timing of vendor payments.
    • Payables and accrued charges decreased due to the seasonality of our Retail segment where we generally receive higher customer payments in North America near year-end and customers drawdown on the balance throughout the year. This was partially offset by a deposit received for the sale of Profertil.
    • Long-term debt, including current portion, increased due to the issuance of $1,000 million of senior notes during the first quarter of 2025, partially offset by the repayment of $500 million of senior notes in the second quarter of 2025.
    • Retained earnings increased as net earnings exceeded dividends declared and share repurchases in the first nine months of 2025. 





    Capital Structure and Management

    Principal debt instruments

    As part of the normal course of business, we closely monitor our liquidity position. We use a combination of cash generated from operations and short-term and long-term debt to finance our operations. We continually evaluate various financing arrangements and may seek to engage in transactions from time to time when market and other conditions are favorable. We were in compliance with our debt covenants and did not have any changes to our credit ratings for the nine months ended September 30, 2025.

    Capital structure (debt and equity)

    ($ millions)

    September 30, 2025

     

    December 31, 2024

    Short-term debt

    2,486

     

    1,534

    Current portion of long-term debt

    538

     

    1,037

    Current portion of lease liabilities

    350

     

    356

    Long-term debt

    9,852

     

    8,881

    Lease liabilities

    954

     

    999

    Shareholders' equity

    25,153

     

    24,442

     

    Commercial paper, credit facilities and other debt

    We have a total facility limit of approximately $7,780 million comprised of several credit facilities available in the jurisdictions where we operate. Our total facility limit decreased in the third quarter of 2025 from a reduction in our unsecured committed revolving term facility limit from $750 million to $500 million. In North America, we have a commercial paper program, which is limited to the undrawn amount under our $4,500 million unsecured revolving term credit facility and excess cash invested in highly liquid securities.

    As at September 30, 2025, we utilized $2,524 million of our total facility limit, which includes $2,228 million of commercial paper outstanding. In the third quarter of 2025, we extended the maturities on our $4,500 million unsecured committed revolving term credit facility to September 4, 2030 and our $500 million unsecured committed revolving term credit facility to September 2, 2026.

    As at September 30, 2025, $220 million in letters of credit were outstanding and committed, with $426 million of remaining credit available under our letter of credit facilities.

    Our long-term debt consists primarily of notes and debentures. See the "Capital Structure and Management" section of our 2024 Annual Report for information on balances, rates and maturities for our notes and debentures. During the first nine months of 2025, we issued $400 million of 4.500 percent senior notes due March 12, 2027 and $600 million of 5.250 percent senior notes due March 12, 2032, and repaid our $500 million 3.000 percent senior notes upon maturity on April 1, 2025. See note 7 to the interim financial statements.

    Outstanding share data

     

    As at November 4, 2025

    Common shares

    483,340,553

    Options to purchase common shares

    2,655,972

     

    For more information on our capital management, see Note 4 to the annual financial statements in our 2024 Annual Report.





    Quarterly Results

    ($ millions, except as otherwise noted)

    Q3 2025

    Q2 2025

    Q1 2025

    Q4 2024

    Q3 2024

    Q2 2024

    Q1 2024

    Q4 2023

    Sales

    6,007

     

    10,438

     

    5,100

     

    5,079

     

    5,348

     

    10,156

     

    5,389

     

    5,664

    Net earnings

    469

     

    1,229

     

    19

     

    118

     

    25

     

    392

     

    165

     

    176

    Net earnings attributable

     

    to equity holders

     

    of Nutrien

    464

     

    1,221

     

    11

     

    113

     

    18

     

    385

     

    158

     

    172

    Net earnings per share

     

    attributable to equity

     

    holders of Nutrien

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Basic

    0.96

     

    2.51

     

    0.02

     

    0.23

     

    0.04

     

    0.78

     

    0.32

     

    0.35

    Diluted

    0.96

     

    2.50

     

    0.02

     

    0.23

     

    0.04

     

    0.78

     

    0.32

     

    0.35

     

    Our quarterly earnings are significantly affected by the seasonality of our business, fertilizer benchmark prices, which have been volatile over the last two years and are affected by demand-supply conditions, grower affordability and weather. See Note 2 to the interim financial statements.

    The following table describes certain items that impacted our quarterly earnings:

    Quarter

    Transaction or Event

    Q2 2024

    $530 million non-cash impairment of assets comprised of a $335 million non-cash impairment of our Retail – Brazil intangible assets and property plant and equipment due to the ongoing market instability and more moderate margin expectations, and a $195 million non-cash impairment of our Geismar Clean Ammonia project property, plant and equipment as we are no longer pursuing the project. Net earnings also included a foreign exchange loss of $220 million on foreign currency derivatives in Brazil.

     

     





    Critical Accounting Estimates

    Our significant accounting policies are disclosed in our 2024 Annual Report. We have discussed the development, selection and application of our key accounting policies, and the critical accounting estimates and assumptions they involve, with the Audit Committee of the Board. Our critical accounting estimates are discussed on pages 65 to 66 of our 2024 Annual Report. There were no material changes to our critical accounting estimates for the three or nine months ended September 30, 2025.





    Controls and Procedures

    Management is responsible for establishing and maintaining adequate internal control over financial reporting ("ICFR"), as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934, as amended, and National Instrument 52-109 Certification of Disclosure in Issuers' Annual and Interim Filings. ICFR is designed to provide reasonable assurance regarding the reliability of financial reporting and preparation of financial statements for external purposes in accordance with IFRS. Any system of ICFR, no matter how well designed, has inherent limitations. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation.

    There has been no change in our ICFR during the three months ended September 30, 2025, that has materially affected, or is reasonably likely to materially affect, our ICFR.





    Forward-Looking Statements

    Certain statements and other information included in this document, including within the "Market Outlook and Guidance" section, constitute "forward-looking information" or "forward-looking statements" (collectively, "forward-looking statements") under applicable securities laws (such statements are often accompanied by words such as "anticipate", "forecast", "expect", "believe", "may", "will", "should", "estimate", "project", "intend" or other similar words). All statements in this document, other than those relating to historical information or current conditions, are forward-looking statements, including, but not limited to:

    Nutrien's business strategies, plans, prospects and opportunities; Nutrien's 2025 full-year guidance, including expectations regarding Retail adjusted EBITDA, Potash sales volumes, Nitrogen sales volumes, Phosphate sales volumes, depreciation and amortization, finance costs, effective tax rate on adjusted net earnings and capital expenditures, including the assumptions and expectations stated therein; expectations regarding our capital allocation intentions and strategies, including our intentions with respect to our strategic actions including the review of strategic alternatives for our Phosphate business, the allocation of sale proceeds from the divestment of our interests in Profertil, and the controlled shut down of our Trinidad Nitrogen facility and options for our Trinidad operations and expectations related thereto; our ability to advance strategic priorities that strengthen our core business and deliver structural improvements to our earnings and free cash flow; expectations regarding various performance targets and our ability to achieve those; capital spending expectations for 2025 and beyond; expectations regarding performance of our operating segments in 2025 and beyond; the expectation that internally generated cash flow, supplemented by available borrowings, if necessary, will be sufficient to meet our anticipated capital expenditures, planned growth and development activities, and other cash requirements; expectations regarding payment of dividends and share repurchases; our operating segment market outlooks and our expectations for market conditions and fundamentals, and the anticipated supply and demand for our products and services, including the expected impact of supply availability on global shipments of phosphate fertilizer and the expected impact of affordability on demand, expected market, industry and growing conditions with respect to crop nutrient application rates, planted acres, farmer crop investment, crop mix, including the need to replenish soil nutrient levels, production volumes and expenses, shipments, natural gas costs and availability, consumption, prices, operating rates and the impact of seasonality, import and export volumes, tariffs, trade or export restrictions, economic sanctions and restrictions, operating rates, inventories, crop development and natural gas curtailments; the negotiation of sales contracts; acquisitions and divestitures and the anticipated benefits thereof; and expectations in connection with our ability to deliver long-term returns to shareholders.

    These forward-looking statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond our control, which could cause actual results to differ materially from such forward-looking statements. As such, undue reliance should not be placed on these forward-looking statements.

    All of the forward-looking statements are qualified by the assumptions that are stated or inherent in such forward-looking statements, including the assumptions referred to below and elsewhere in this document. Although we believe that these assumptions are reasonable, having regard to our experience and our perception of historical trends, this list is not exhaustive of the factors that may affect any of the forward-looking statements and the reader should not place undue reliance on these assumptions and such forward-looking statements. Current conditions, economic and otherwise, render assumptions, although reasonable when made, subject to greater uncertainty. Nutrien cautions that there are no guarantees that the review of strategic alternatives for our Phosphate business will result in a transaction or if a transaction is undertaken, as to its terms, timing or benefits.

    The additional key assumptions that have been made in relation to the operation of our business as currently planned and our ability to achieve our business objectives include, among other things, assumptions with respect to: our ability to successfully implement our business strategies, growth and capital allocation investments and initiatives that we will conduct our operations and achieve results of operations as anticipated; growth in crop nutrient sales volumes; our ability to successfully complete, integrate and realize the anticipated benefits of our already completed and future acquisitions and divestitures; increased proprietary products gross margin; continued Retail recovery in Brazil; a return to historical average crop protection product margin percentages; continued reliability improvements; higher operating rates in Phosphate and Nitrogen; that future business, regulatory and industry conditions will be within the parameters expected by us, including with respect to prices, expenses, margins, demand, supply, product availability, shipments, consumption, weather conditions, supplier agreements, product distribution agreements, inventory levels, exports, tariffs, including general or retaliatory tariffs, trade restrictions, international trade arrangements, government support, crop development and cost of labor and interest, exchange and effective tax rates; potash demand growth in offshore markets; global economic conditions and the accuracy of our market outlook expectations for 2025 and in the future; assumptions related to our assessment of recoverable amount estimates of our assets; our intention to complete share repurchases under our normal course issuer bid programs, the funding of such share repurchases, existing and future market conditions, including with respect to the price of our common shares, capital allocation priorities and compliance with respect to applicable limitations under securities laws and regulations and stock exchange policies and assumptions related to our ability to fund our dividends at the current level; our expectations regarding the impacts, direct and indirect, of certain geopolitical conflicts, including the war in Eastern Europe and the conflict in the Middle East on, among other things, global supply and demand, including for crop nutrients, energy and commodity prices, global interest rates, supply chains and the global macroeconomic environment, including inflation; the adequacy of our cash generated from operations and our ability to access our credit facilities or capital markets for additional sources of financing; our ability to identify suitable candidates for acquisitions and divestitures and negotiate acceptable terms; availability of investment opportunities that align with our strategic priorities and growth strategy; our ability to maintain investment grade ratings and achieve our performance targets; and our ability to successfully negotiate sales and other contracts and our ability to successfully implement new initiatives and programs.

    Events or circumstances that could cause actual results to differ materially from those in the forward-looking statements include, but are not limited to: the review of strategic alternative for our Phosphate business, process and the timing thereof, whether the review will result in Nutrien undertaking a transaction, and if so, the terms and timing relating thereto, the completion thereof and realizing benefits resulting therefrom, general global economic, market and business conditions; failure to achieve expected results of our business strategy, capital allocation initiatives, results of operations or targets, such as our targeted $200 million in annual consolidated cost savings, expected capital expenditures in 2025, delivering upstream fertilizer sales volume growth and advancing high-return downstream Retail growth opportunities; failure to complete announced and future acquisitions or divestitures at all or on the expected terms and within the expected timeline; seasonality; climate change and weather conditions, including impacts from regional flooding and/or drought conditions; crop planted acreage, yield and prices; the supply and demand and price levels for our products; governmental and regulatory requirements and actions by governmental authorities, including changes in government policy (including general or retaliatory tariffs, trade restrictions, or other changes to international trade arrangements; the effects of current and future multinational trade agreements or other developments affecting the level of trade or export restrictions and climate change initiatives), government ownership requirements, changes in environmental, tax, antitrust and other laws or regulations and the interpretation thereof; political or military risks, including civil unrest, actions by armed groups or conflict and malicious acts including terrorism and industrial espionage; our ability to access sufficient, cost-effective and timely transportation, distribution and storage of products (including potential rail transportation and port disruptions due to labor strikes and/or work stoppages or other similar actions); the occurrence of a major environmental or safety incident or becoming subject to legal or regulatory proceedings; innovation and cybersecurity risks related to our systems, including our costs of addressing or mitigating such risks; counterparty and sovereign risk; delays in completion of turnarounds at our major facilities or challenges related to our major facilities that are out of our control; interruptions of or constraints in availability of key inputs, including natural gas and sulfur; any significant impairment of the carrying amount of certain assets; the risk that rising interest rates and/or deteriorated business operating results may result in the further impairment of assets or goodwill attributed to certain of our cash generating units; risks related to reputational loss; certain complications that may arise in our mining processes; the ability to attract, engage and retain skilled employees and strikes or other forms of work stoppages; geopolitical conflicts, including the war in Eastern Europe and the conflict in the Middle East, and their potential impact on, among other things, global market conditions and supply and demand, including for crop nutrients, energy and commodity prices, interest rates, supply chains and the global economy generally; our ability to execute on our strategies related to environmental, social and governance matters, and achieve related expectations, targets and commitments, including risks associated with disclosure thereof; and other risk factors detailed from time to time in Nutrien reports filed with the Canadian securities regulators and the SEC.

    The purpose of our Retail adjusted EBITDA, depreciation and amortization, finance costs, effective tax rate and capital expenditures guidance ranges are to assist readers in understanding our expected and targeted financial results, and this information may not be appropriate for other purposes.

    The forward-looking statements in this document are made as of the date hereof and Nutrien disclaims any intention or obligation to update or revise any forward-looking statements in this document as a result of new information or future events, except as may be required under applicable Canadian securities legislation or applicable US federal securities laws.





    Terms and Definitions

    For the definitions of certain financial and non-financial terms used in this document, as well as a list of abbreviated company names and sources, see the "Terms and definitions" section of our 2024 Annual Report. All references to per share amounts pertain to diluted net earnings (loss) per share, "n/m" indicates information that is not meaningful, and all financial amounts are stated in millions of US dollars, unless otherwise noted.





    About Nutrien

    Nutrien is a leading global provider of crop inputs and services. We operate a world-class network of production, distribution and ag retail facilities that positions us to efficiently serve the needs of farmers. We focus on creating long-term value by prioritizing investments that strengthen the advantages of our business across the ag value chain and by maintaining access to the resources and the relationships with stakeholders needed to achieve our goals.

    More information about Nutrien can be found at www.nutrien.com.

    Selected financial data for download can be found in our data tool at https://www.nutrien.com/investors/interactive-data-tool

    Such data is not incorporated by reference herein.

    Nutrien will host a Conference Call on Thursday, November 6, 2025 at 10:00 a.m. Eastern Time.

    Telephone conference dial-in numbers:

    • From Canada and the US: 1-800-990-2777
    • International: 1-416-855-9085
    • Conference ID: 26207. Please dial in 15 minutes prior to ensure you are placed on the call in a timely manner.

    Live Audio Webcast: Visit https://www.nutrien.com/news/events/2025-q3-earnings-conference-call





    Non-GAAP Financial Measures

    We use both IFRS measures and certain non-GAAP financial measures to assess performance. Non-GAAP financial measures are financial measures disclosed by the Company that: (a) depict historical or expected future financial performance, financial position or cash flow of the Company; (b) with respect to their composition, exclude amounts that are included in, or include amounts that are excluded from, the composition of the most directly comparable financial measure disclosed in the primary financial statements of the Company; (c) are not disclosed in the financial statements of the Company; and (d) are not a ratio, fraction, percentage or similar representation. Non-GAAP ratios are financial measures disclosed by the Company that are in the form of a ratio, fraction, percentage or similar representation that has a non-GAAP financial measure as one or more of its components, and that are not disclosed in the financial statements of the Company.

    These non-GAAP financial measures and non-GAAP ratios are not standardized financial measures under IFRS and, therefore, are unlikely to be comparable to similar financial measures presented by other companies. Management believes these non-GAAP financial measures and non-GAAP ratios provide transparent and useful supplemental information to help investors evaluate our financial performance, financial condition and liquidity using the same measures as management. These non-GAAP financial measures and non-GAAP ratios should not be considered as a substitute for, or superior to, measures of financial performance prepared in accordance with IFRS.

    The following section outlines our non-GAAP financial measures and non-GAAP ratios, their compositions, and why management uses each measure. It also includes reconciliations to the most directly comparable IFRS measures. Except as otherwise described herein, our non-GAAP financial measures and non-GAAP ratios are calculated on a consistent basis from period to period and are adjusted for specific items in each period, as applicable. As additional non-recurring or unusual items arise in the future, we generally exclude these items in our calculations.

    Adjusted EBITDA (Consolidated)

    Most directly comparable IFRS financial measure: Net earnings (loss).

    Definition: Adjusted EBITDA is calculated as net earnings (loss) before finance costs, income taxes, depreciation and amortization, share-based compensation and foreign exchange gain/loss (net of related derivatives). We also adjust this measure for the following other income and expenses that are excluded when management evaluates the performance of our day-to-day operations: certain integration and restructuring related costs, impairment or reversal of impairment of assets, gain or loss on disposal of certain businesses and investments, asset retirement obligations ("ARO") and accrued environmental costs ("ERL") related to our non-operating sites, and loss related to financial instruments in Argentina.

    Why we use the measure and why it is useful to investors: It is not impacted by long-term investment and financing decisions, but rather focuses on the performance of our day-to-day operations. It provides a measure of our ability to service debt and to meet other payment obligations and as a component of employee remuneration calculations.

     

    Three Months Ended

    September 30

     

    Nine Months Ended

    September 30

    ($ millions)

    2025

     

    2024

     

    2025

     

    2024

    Net earnings

    469

     

    25

     

    1,717

     

    582

    Finance costs

    170

     

    184

     

    504

     

    525

    Income tax expense (recovery)

    168

     

    (13)

     

    594

     

    352

    Depreciation and amortization

    617

     

    598

     

    1,802

     

    1,749

    EBITDA 1

    1,424

     

    794

     

    4,617

     

    3,208

    Adjustments:

     

     

     

     

     

     

     

    Share-based compensation expense

    28

     

    1

     

    119

     

    17

    Foreign exchange (gain) loss, net of related

    derivatives

    (11)

     

    31

     

    18

     

    359

    ARO/ERL related (income) expenses for

    non-operating sites

    (10)

     

    184

     

    (7)

     

    152

    Loss related to financial instruments in Argentina

    ‐

     

    ‐

     

    ‐

     

    34

    Restructuring costs

    ‐

     

    ‐

     

    22

     

    ‐

    Impairment of assets

    ‐

     

    ‐

     

    ‐

     

    530

    Adjusted EBITDA

    1,431

     

    1,010

     

    4,769

     

    4,300

    1 EBITDA is calculated as net earnings before finance costs, income taxes, and depreciation and amortization.

     

    Adjusted Net Earnings and Adjusted Net Earnings Per Share

    Most directly comparable IFRS financial measure: Net earnings (loss) and diluted net earnings (loss) per share.

    Definition: Adjusted net earnings and related per share information are calculated as net earnings (loss) before share-based compensation and foreign exchange gain/loss (net of related derivatives), net of tax. We also adjust this measure for the following other income and expenses (net of tax) that are excluded when management evaluates the performance of our day-to-day operations: certain integration and restructuring related costs, impairment or reversal of impairment of assets, gain or loss on disposal of certain businesses and investments, gain or loss on early extinguishment of debt or on settlement of derivatives due to discontinuance of hedge accounting, asset retirement obligations and accrued environmental costs related to our non-operating sites, loss related to financial instruments in Argentina, change in recognition of tax losses and deductible temporary differences related to impairments and certain changes to tax declarations. We generally apply the annual forecasted effective tax rate to specific adjustments during the year, and at year-end, we apply the actual effective tax rate.

    Why we use the measure and why it is useful to investors: Focuses on the performance of our day-to-day operations and is used as a component of employee remuneration calculations.

     

    Three Months Ended

    September 30, 2025

     

    Nine Months Ended

    September 30, 2025

    ($ millions, except as otherwise noted)

    Increases

    (Decreases)

     

    Post-Tax

     

    Per

    Diluted

    Share

     

    Increases

    (Decreases)

     

    Post-Tax

     

    Per

    Diluted

    Share

    Net earnings attributable to equity holders of Nutrien

     

     

    464

     

    0.96

     

     

     

    1,696

     

    3.48

    Adjustments:

     

     

     

     

     

     

     

     

     

     

     

    Share-based compensation expense

    28

     

    22

     

    0.05

     

    119

     

    90

     

    0.18

    Foreign exchange (gain) loss, net of related derivatives

    (11)

     

    (9)

     

    (0.02)

     

    18

     

    14

     

    0.03

    Restructuring costs

    ‐

     

    ‐

     

    ‐

     

    22

     

    18

     

    0.04

    ARO/ERL related (income) for non-operating sites

    (10)

     

    (8)

     

    (0.02)

     

    (7)

     

    (5)

     

    (0.01)

    Sub-total adjustments

    7

     

    5

     

    0.01

     

    152

     

    117

     

    0.24

    Adjusted net earnings

     

     

    469

     

    0.97

     

     

     

    1,813

     

    3.72

     

     

    Three Months Ended

    September 30, 2024

     

    Nine Months Ended

    September 30, 2024

    ($ millions, except as otherwise noted)

    Increases

    (Decreases)

     

    Post-Tax

     

    Per

    Diluted

    Share

     

    Increases

    (Decreases)

     

    Post-Tax

     

    Per

    Diluted

    Share

    Net earnings attributable to equity holders of Nutrien

     

     

    18

     

    0.04

     

     

     

    561

     

    1.13

    Adjustments:

     

     

     

     

     

     

     

     

     

     

     

    Share-based compensation expense

    1

     

    1

     

    ‐

     

    17

     

    13

     

    0.03

    Foreign exchange loss, net of related derivatives

    31

     

    38

     

    0.08

     

    359

     

    361

     

    0.73

    Impairment of assets

    ‐

     

    ‐

     

    ‐

     

    530

     

    491

     

    1.00

    ARO/ERL related expenses for non-operating sites

    184

     

    134

     

    0.27

     

    152

     

    112

     

    0.22

    Loss related to financial instruments in Argentina

    ‐

     

    ‐

     

    ‐

     

    34

     

    34

     

    0.07

    Sub-total adjustments

    216

     

    173

     

    0.35

     

    1,092

     

    1,011

     

    2.05

    Adjusted net earnings

     

     

    191

     

    0.39

     

     

     

    1,572

     

    3.18

     

    Effective Tax Rate on Adjusted Net Earnings Guidance

    Effective tax rate on adjusted net earnings guidance is a forward-looking non-GAAP financial measure as it includes adjusted net earnings, which is a non-GAAP financial measure. It is provided to assist readers in understanding our expected financial results. Effective tax rate on adjusted net earnings guidance excludes certain items that management is aware of that permit management to focus on the performance of our operations (see the Adjusted Net Earnings and Adjusted Net Earnings Per Share section for items generally adjusted). We do not provide a reconciliation of this forward-looking measure to the most directly comparable financial measures calculated and presented in accordance with IFRS because a meaningful or accurate calculation of reconciling items and the information is not available without unreasonable effort due to unknown variables, including the timing and amount of certain reconciling items, and the uncertainty related to future results. These unknown variables may include unpredictable transactions of significant value that may be inherently difficult to determine without unreasonable efforts. The probable significance of such unavailable information, which could be material to future results, cannot be addressed.

    Gross Margin Excluding Depreciation and Amortization Per Tonne – Manufactured Product

    Most directly comparable IFRS financial measure: Gross margin.

    Definition: Gross margin per tonne less depreciation and amortization per tonne for manufactured products. Reconciliations are provided in the "Segment Results" section.

    Why we use the measure and why it is useful to investors: Focuses on the performance of our day-to-day operations, which excludes the effects of items that primarily reflect the impact of long-term investment and financing decisions.

    Potash Controllable Cash Cost of Product Manufactured ("COPM") Per Tonne

    Most directly comparable IFRS financial measure: Cost of goods sold ("COGS") for the Potash segment.

    Definition: Total Potash COGS excluding depreciation and amortization expense included in COPM, royalties, natural gas costs and carbon taxes, change in inventory, and other adjustments, divided by potash production tonnes.

    Why we use the measure and why it is useful to investors: To assess operational performance. Potash controllable cash COPM excludes the effects of production from other periods and the impacts of our long-term investment decisions, supporting a focus on the performance of our day-to-day operations. Potash controllable cash COPM also excludes royalties and natural gas costs and carbon taxes, which management does not consider controllable, as they are primarily driven by regulatory and market conditions.

     

    Three Months Ended

    September 30

     

    Nine Months Ended

    September 30

    ($ millions, except as otherwise noted)

    2025

     

    2024

     

    2025

     

    2024

    Total COGS – Potash

    437

     

    422

     

    1,257

     

    1,139

    Change in inventory

    (45)

     

    (51)

     

    (96)

     

    (30)

    Other adjustments 1

    2

     

    (5)

     

    (19)

     

    (14)

    COPM

    394

     

    366

     

    1,142

     

    1,095

    Depreciation and amortization in COPM

    (157)

     

    (145)

     

    (449)

     

    (439)

    Royalties in COPM

    (26)

     

    (23)

     

    (68)

     

    (62)

    Natural gas costs and carbon taxes in COPM

    (8)

     

    (7)

     

    (30)

     

    (27)

    Controllable cash COPM

    203

     

    191

     

    595

     

    567

    Production volumes (tonnes – thousands)

    3,607

     

    3,696

     

    10,427

     

    10,836

    Potash controllable cash COPM per tonne

    56

     

    52

     

    57

     

    52

    1 Other adjustments include unallocated production overhead that is recognized as part of cost of goods sold but is not included in the measurement of inventory and changes in inventory balances.

     

    Nutrien Financial Adjusted Net Interest Margin

    Definition: Nutrien Financial revenue less deemed interest expense divided by average Nutrien Financial net receivables outstanding for the last four rolling quarters.

    Why we use the measure and why it is useful to investors: Used by credit rating agencies and others to evaluate the financial performance of Nutrien Financial.

     

    Rolling Four Quarters Ended September 30, 2025

    ($ millions, except as otherwise noted)

    Q4 2024

     

    Q1 2025

     

    Q2 2025

     

    Q3 2025

     

    Total/Average

    Nutrien Financial revenue

    77

     

    70

     

    135

     

    89

     

     

    Deemed interest expense 1

    (45)

     

    (29)

     

    (49)

     

    (52)

     

     

    Net interest

    32

     

    41

     

    86

     

    37

     

    196

     

     

     

     

     

     

     

     

     

     

    Average Nutrien Financial net receivables

    2,877

     

    2,569

     

    4,645

     

    4,452

     

    3,636

    Nutrien Financial adjusted net interest margin (%)

     

     

     

     

     

     

     

     

    5.4

     

     

     

     

     

     

     

     

     

     

     

    Rolling Four Quarters Ended December 31, 2024

    ($ millions, except as otherwise noted)

    Q1 2024

     

    Q2 2024

     

    Q3 2024

     

    Q4 2024

     

    Total/Average

    Nutrien Financial revenue

    66

     

    133

     

    85

     

    77

     

     

    Deemed interest expense 1

    (27)

     

    (50)

     

    (52)

     

    (45)

     

     

    Net interest

    39

     

    83

     

    33

     

    32

     

    187

     

     

     

     

     

     

     

     

     

     

    Average Nutrien Financial net receivables

    2,489

     

    4,560

     

    4,318

     

    2,877

     

    3,561

    Nutrien Financial adjusted net interest margin (%)

     

     

     

     

     

     

     

     

    5.3

    1 Average borrowing rate applied to the notional debt required to fund the portfolio of receivables from customers monitored and serviced by Nutrien Financial.

     

    Retail Cash Operating Coverage Ratio

    Definition: Retail selling, general and administrative, and other expenses (income), excluding depreciation and amortization expense, divided by Retail gross margin excluding depreciation and amortization expense in cost of goods sold, for the last four rolling quarters.

    Why we use the measure and why it is useful to investors: To understand the costs and underlying economics of our Retail operations and to assess our Retail operating performance and ability to generate cash flow.

     

    Rolling Four Quarters Ended September 30, 2025

    ($ millions, except as otherwise noted)

    Q4 2024

     

    Q1 2025

     

    Q2 2025

     

    Q3 2025

     

    Total

    Selling expenses

    808

     

    755

     

    948

     

    792

     

    3,303

    General and administrative expenses

    37

     

    44

     

    44

     

    44

     

    169

    Other (income) expenses

    (8)

     

    25

     

    54

     

    40

     

    111

    Operating expenses

    837

     

    824

     

    1,046

     

    876

     

    3,583

    Depreciation and amortization in operating expenses

    (186)

     

    (179)

     

    (172)

     

    (179)

     

    (716)

    Operating expenses excluding depreciation and amortization

    651

     

    645

     

    874

     

    697

     

    2,867

     

     

     

     

     

     

     

     

     

     

    Gross margin

    986

     

    686

     

    2,018

     

    922

     

    4,612

    Depreciation and amortization in cost of goods sold

    5

     

    5

     

    5

     

    5

     

    20

    Gross margin excluding depreciation and amortization

    991

     

    691

     

    2,023

     

    927

     

    4,632

    Cash operating coverage ratio (%)

     

     

     

     

     

     

     

     

    62

     

     

     

     

     

     

     

     

     

     

     

    Rolling Four Quarters Ended December 31, 2024

    ($ millions, except as otherwise noted)

    Q1 2024

     

    Q2 2024

     

    Q3 2024

     

    Q4 2024

     

    Total

    Selling expenses

    790

     

    1,005

     

    815

     

    808

     

    3,418

    General and administrative expenses

    52

     

    51

     

    51

     

    37

     

    191

    Other expenses (income)

    22

     

    41

     

    32

     

    (8)

     

    87

    Operating expenses

    864

     

    1,097

     

    898

     

    837

     

    3,696

    Depreciation and amortization in operating expenses

    (190)

     

    (193)

     

    (182)

     

    (186)

     

    (751)

    Operating expenses excluding depreciation and amortization

    674

     

    904

     

    716

     

    651

     

    2,945

     

     

     

     

     

     

     

     

     

     

    Gross margin

    747

     

    2,029

     

    859

     

    986

     

    4,621

    Depreciation and amortization in cost of goods sold

    4

     

    3

     

    8

     

    5

     

    20

    Gross margin excluding depreciation and amortization

    751

     

    2,032

     

    867

     

    991

     

    4,641

    Cash operating coverage ratio (%)

     

     

     

     

     

     

     

     

    63

     

    Retail Adjusted Average Working Capital to Sales and Retail Adjusted Average Working Capital to Sales Excluding Nutrien Financial

    Definition: Retail adjusted average working capital divided by Retail adjusted sales for the last four rolling quarters. We exclude in our calculations the sales and working capital of certain acquisitions during the first year following the acquisition. We also look at this metric excluding Nutrien Financial revenue and working capital.

    Why we use the measure and why it is useful to investors: To evaluate operational efficiency. A lower or higher percentage represents increased or decreased efficiency, respectively. The metric excluding Nutrien Financial shows the impact that the working capital of Nutrien Financial has on the ratio.

     

    Rolling Four Quarters Ended September 30, 2025

    ($ millions, except as otherwise noted)

    Q4 2024

     

    Q1 2025

     

    Q2 2025

     

    Q3 2025

     

    Average/Total

    Current assets

    10,360

     

    11,510

     

    11,442

     

    10,823

     

     

    Current liabilities

    (8,028)

     

    (7,561)

     

    (8,051)

     

    (5,348)

     

     

    Working capital

    2,332

     

    3,949

     

    3,391

     

    5,475

     

    3,787

    Working capital from certain recent acquisitions

    ‐

     

    ‐

     

    ‐

     

    ‐

     

     

    Adjusted working capital

    2,332

     

    3,949

     

    3,391

     

    5,475

     

    3,787

    Nutrien Financial working capital

    (2,877)

     

    (2,569)

     

    (4,645)

     

    (4,452)

     

     

    Adjusted working capital excluding Nutrien Financial

    (545)

     

    1,380

     

    (1,254)

     

    1,023

     

    151

     

     

     

     

     

     

     

     

     

     

    Sales

    3,179

     

    3,090

     

    7,959

     

    3,427

     

     

    Sales from certain recent acquisitions

    ‐

     

    ‐

     

    ‐

     

    ‐

     

     

    Adjusted sales

    3,179

     

    3,090

     

    7,959

     

    3,427

     

    17,655

    Nutrien Financial revenue

    (77)

     

    (70)

     

    (135)

     

    (89)

     

     

    Adjusted sales excluding Nutrien Financial

    3,102

     

    3,020

     

    7,824

     

    3,338

     

    17,284

     

     

     

     

     

     

     

     

     

     

    Adjusted average working capital to sales (%)

     

     

     

     

     

     

     

     

    21

    Adjusted average working capital to sales excluding Nutrien Financial (%)

     

     

     

    1

     

     

     

     

     

     

     

     

     

     

     

    Rolling Four Quarters Ended December 31, 2024

    ($ millions, except as otherwise noted)

    Q1 2024

     

    Q2 2024

     

    Q3 2024

     

    Q4 2024

     

    Average/Total

    Current assets

    11,821

     

    11,181

     

    10,559

     

    10,360

     

     

    Current liabilities

    (8,401)

     

    (8,002)

     

    (5,263)

     

    (8,028)

     

     

    Working capital

    3,420

     

    3,179

     

    5,296

     

    2,332

     

    3,557

    Working capital from certain recent acquisitions

    ‐

     

    ‐

     

    ‐

     

    ‐

     

     

    Adjusted working capital

    3,420

     

    3,179

     

    5,296

     

    2,332

     

    3,557

    Nutrien Financial working capital

    (2,489)

     

    (4,560)

     

    (4,318)

     

    (2,877)

     

     

    Adjusted working capital excluding Nutrien Financial

    931

     

    (1,381)

     

    978

     

    (545)

     

    (4)

     

     

     

     

     

     

     

     

     

     

    Sales

    3,308

     

    8,074

     

    3,271

     

    3,179

     

     

    Sales from certain recent acquisitions

    ‐

     

    ‐

     

    ‐

     

    ‐

     

     

    Adjusted sales

    3,308

     

    8,074

     

    3,271

     

    3,179

     

    17,832

    Nutrien Financial revenue

    (66)

     

    (133)

     

    (85)

     

    (77)

     

     

    Adjusted sales excluding Nutrien Financial

    3,242

     

    7,941

     

    3,186

     

    3,102

     

    17,471

     

     

     

     

     

     

     

     

     

     

    Adjusted average working capital to sales (%)

     

     

     

     

     

     

     

     

    20

    Adjusted average working capital to sales excluding Nutrien Financial (%)

     

     

     

    ‐

     
     

    Other Financial Measures

    Selected Additional Financial Data

    Nutrien Financial

    As at September 30, 2025

    As at

    December 31, 2024

    ($ millions)

    Current

    <31 Days

    Past Due

    31–90 Days

    Past Due

    >90 Days

    Past Due

    Gross Receivables

    Allowance 1

    Net

    Receivables 2

    Net

    Receivables

    North America

    3,304

    87

    75

    236

    3,702

    (81)

    3,621

    2,178

    International

    722

    62

    25

    33

    842

    (11)

    831

    699

    Nutrien Financial

    receivables

    4,026

    149

    100

    269

    4,544

    (92)

    4,452

    2,877

    1 Bad debt expense on the above receivables for the nine months ended September 30, 2025 was $46 million, in the Retail segment.

    2 In 2025, we assume a debt-to-equity ratio of 9:1 (2024 – 7:1) in funding Nutrien Financial receivables, based on the underlying credit quality of the assets.

     

    Supplementary Financial Measures

    Supplementary financial measures are financial measures disclosed by the Company that (a) are, or are intended to be, disclosed on a periodic basis to depict the historical or expected future financial performance, financial position or cash flow of the Company, (b) are not disclosed in the financial statements of the Company, (c) are not non-GAAP financial measures, and (d) are not non-GAAP ratios.

    The following section provides an explanation of the composition of those supplementary financial measures, if not previously provided.

    Sustaining capital expenditures: Represents capital expenditures that are required to sustain operations at existing levels and include major repairs and maintenance and plant turnarounds.

    Investing capital expenditures: Represents capital expenditures related to significant expansions of current operations or to create cost savings (synergies). Investing capital expenditures exclude capital outlays for business acquisitions and equity-accounted investees.

    Mine development and pre-stripping capital expenditures: Represents capital expenditures that are required for activities to open new areas underground and/or develop a mine or ore body to allow for future production mining and activities required to prepare and/or access the ore, i.e., removal of an overburden that allows access to the ore.

    Cash used for dividends and share repurchases: Calculated as dividends paid to Nutrien's shareholders plus repurchase of common shares as reflected in the unaudited condensed consolidated statements of cash flows. This measure is useful as it represents return of capital to shareholders.





    Condensed Consolidated Financial Statements

    Unaudited

    Condensed Consolidated Statements of Earnings

     

     

    Three Months Ended

     

    Nine Months Ended

     

     

    September 30

     

    September 30

    ($ millions, except as otherwise noted)

    Note

    2025

     

    2024

     

    2025

     

    2024

    Sales

    2, 9

    6,007

     

    5,348

     

    21,545

     

    20,893

    Freight, transportation and distribution

     

    272

     

    263

     

    738

     

    741

    Cost of goods sold

     

    3,771

     

    3,585

     

    14,348

     

    14,203

    Gross Margin

     

    1,964

     

    1,500

     

    6,459

     

    5,949

    Selling expenses

     

    795

     

    820

     

    2,503

     

    2,622

    General and administrative expenses

     

    144

     

    156

     

    444

     

    468

    Provincial mining taxes

     

    124

     

    74

     

    289

     

    210

    Share-based compensation expense

     

    28

     

    1

     

    119

     

    17

    Impairment of assets

     

    ‐

     

    ‐

     

    ‐

     

    530

    Foreign exchange (gain) loss, net of related derivatives

    6

    (11)

     

    31

     

    18

     

    359

    Other expenses

    3

    77

     

    222

     

    271

     

    284

    Earnings Before Finance Costs and Income Taxes

    807

     

    196

     

    2,815

     

    1,459

    Finance costs

     

    170

     

    184

     

    504

     

    525

    Earnings Before Income Taxes

     

    637

     

    12

     

    2,311

     

    934

    Income tax expense (recovery)

    4

    168

     

    (13)

     

    594

     

    352

    Net Earnings

     

    469

     

    25

     

    1,717

     

    582

    Attributable to

     

     

     

     

     

     

     

     

    Equity holders of Nutrien

     

    464

     

    18

     

    1,696

     

    561

    Non-controlling interest

     

    5

     

    7

     

    21

     

    21

    Net Earnings

     

    469

     

    25

     

    1,717

     

    582

     

     

     

     

     

     

     

     

     

    Net Earnings Per Share Attributable to Equity Holders of Nutrien ("EPS")

    Basic

     

    0.96

     

    0.04

     

    3.48

     

    1.13

    Diluted

     

    0.96

     

    0.04

     

    3.48

     

    1.13

    Weighted average shares outstanding for basic EPS

     

    485,583,000

     

    494,743,000

     

    487,445,000

     

    494,653,000

    Weighted average shares outstanding for diluted EPS

     

    485,776,000

     

    494,857,000

     

    487,624,000

     

    494,851,000

     

     

     

     

     

     

     

     

     

    (See Notes to the Condensed Consolidated Financial Statements)

     

    Condensed Consolidated Statements of Comprehensive Income

     

    Three Months Ended

     

    Nine Months Ended

     

    September 30

     

    September 30

    ($ millions, net of related income taxes)

    2025

     

    2024

     

    2025

     

    2024

    Net Earnings

    469

     

    25

     

    1,717

     

    582

    Other comprehensive (loss) income

     

     

     

     

     

     

     

    Item that will not be reclassified to net earnings:

     

     

     

     

     

     

     

    Net fair value gain (loss) on investments

    ‐

     

    35

     

    (18)

     

    53

    Items that have been or may be subsequently reclassified to net earnings:

     

     

     

     

     

     

     

    (Loss) gain on currency translation of foreign operations

    (5)

     

    85

     

    196

     

    28

    Other

    (13)

     

    2

     

    13

     

    (17)

    Other Comprehensive (Loss) Income

    (18)

     

    122

     

    191

     

    64

    Comprehensive Income

    451

     

    147

     

    1,908

     

    646

    Attributable to

     

     

     

     

     

     

     

    Equity holders of Nutrien

    446

     

    139

     

    1,886

     

    625

    Non-controlling interest

    5

     

    8

     

    22

     

    21

    Comprehensive Income

    451

     

    147

     

    1,908

     

    646

     

     

     

     

     

     

     

     

    (See Notes to the Condensed Consolidated Financial Statements)

     

    Condensed Consolidated Statements of Cash Flows

     

     

    Three Months Ended

     

    Nine Months Ended

     

     

    September 30

     

    September 30

    ($ millions)

    Note

    2025

     

    2024

     

    2025

     

    2024

    Operating Activities

     

     

     

     

     

     

     

     

    Net earnings

     

    469

     

    25

     

    1,717

     

    582

    Adjustments for:

     

     

     

     

     

     

     

     

    Depreciation and amortization

     

    617

     

    598

     

    1,802

     

    1,749

    Share-based compensation expense

     

    28

     

    1

     

    119

     

    17

    Impairment of assets

     

    ‐

     

    ‐

     

    ‐

     

    530

    Provision for (recovery of) deferred income tax

     

    195

     

    (36)

     

    227

     

    15

    Net (undistributed) distributed earnings of equity-accounted investees

     

    (19)

     

    (24)

     

    66

     

    14

    Fair value adjustment to derivatives

    6

    (2)

     

    (180)

     

    6

     

    6

    Loss related to financial instruments in Argentina

    3

    ‐

     

    ‐

     

    ‐

     

    34

    Long-term income tax receivables and payables

     

    2

     

    9

     

    18

     

    17

    Other long-term assets, liabilities and miscellaneous

     

    (15)

     

    251

     

    (55)

     

    321

    Cash from operations before working capital changes

     

    1,275

     

    644

     

    3,900

     

    3,285

    Changes in non-cash operating working capital:

     

     

     

     

     

     

     

     

    Receivables

     

    357

     

    418

     

    (2,248)

     

    (2,394)

    Inventories and prepaid expenses and other current assets

     

    257

     

    373

     

    1,877

     

    2,265

    Payables and accrued charges

     

    (2,315)

     

    (2,343)

     

    (2,499)

     

    (2,744)

    Cash (Used in) Provided by Operating Activities

     

    (426)

     

    (908)

     

    1,030

     

    412

    Investing Activities

     

     

     

     

     

     

     

     

    Capital expenditures 1

     

    (530)

     

    (508)

     

    (1,254)

     

    (1,387)

    Business acquisitions, net of cash acquired

     

    (1)

     

    (2)

     

    (12)

     

    (6)

    Proceeds from (purchase of) investments, held within three months, net

     

    1

     

    (15)

     

    (68)

     

    (30)

    Purchase of investments

     

    ‐

     

    (1)

     

    (93)

     

    (112)

    Proceeds from sale of investments

    5

    146

     

    41

     

    422

     

    59

    Net changes in non-cash working capital

     

    23

     

    30

     

    (55)

     

    (55)

    Other

     

    (22)

     

    (51)

     

    (61)

     

    (83)

    Cash Used in Investing Activities

     

    (383)

     

    (506)

     

    (1,121)

     

    (1,614)

    Financing Activities

     

     

     

     

     

     

     

     

    Proceeds from debt, maturing within three months, net

     

    591

     

    1,378

     

    925

     

    1,089

    Proceeds from debt

    7

    ‐

     

    ‐

     

    998

     

    998

    Repayment of debt

    7

    (27)

     

    (43)

     

    (562)

     

    (132)

    Repayment of principal portion of lease liabilities

     

    (97)

     

    (98)

     

    (313)

     

    (300)

    Dividends paid to Nutrien's shareholders

    8

    (265)

     

    (268)

     

    (798)

     

    (795)

    Repurchase of common shares, inclusive of related tax

    8

    (148)

     

    (50)

     

    (401)

     

    (50)

    Issuance of common shares

     

    ‐

     

    7

     

    29

     

    16

    Other

     

    (3)

     

    (4)

     

    (34)

     

    (40)

    Cash Provided by (Used in) Financing Activities

     

    51

     

    922

     

    (156)

     

    786

    Effect of Exchange Rate Changes on Cash and Cash Equivalents

     

    (5)

     

    8

     

    18

     

    (5)

    Decrease in Cash and Cash Equivalents

     

    (763)

     

    (484)

     

    (229)

     

    (421)

    Cash and Cash Equivalents – Beginning of Period

     

    1,387

     

    1,004

     

    853

     

    941

    Cash and Cash Equivalents – End of Period

     

    624

     

    520

     

    624

     

    520

    Cash and cash equivalents is composed of:

     

     

     

     

     

     

     

     

    Cash

     

    514

     

    472

     

    514

     

    472

    Short-term investments

     

    110

     

    48

     

    110

     

    48

     

     

    624

     

    520

     

    624

     

    520

    Supplemental Cash Flows Information

     

     

     

     

     

     

     

     

    Interest paid

     

    166

     

    148

     

    518

     

    496

    Income taxes paid

     

    213

     

    127

     

    201

     

    260

    Total cash outflow for leases

     

    134

     

    134

     

    423

     

    418

    1 Includes additions to property, plant and equipment, and intangible assets for the three months ended September 30, 2025 of $498 million and $32 million (2024 – $475 million and $33 million), respectively, and for the nine months ended September 30, 2025 of $1,175 million and $79 million (2024 – $1,290 million and $97 million), respectively.

     

    (See Notes to the Condensed Consolidated Financial Statements)

     
     

    Condensed Consolidated Statements of Changes in Shareholders' Equity

     

     

     

     

     

     

     

    Accumulated Other Comprehensive

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    (Loss) Income ("AOCI")

     

     

     

     

     

     

     

     

    ($ millions, inclusive of related tax, except as otherwise noted)

    Number of

    Common

    Shares

     

    Share

    Capital

     

    Contributed

    Surplus

     

    (Loss) Gain

    on Currency

    Translation

    of Foreign

    Operations

     

    Other

     

    Total

    AOCI

     

    Retained

    Earnings

     

    Equity

    Holders

    of

    Nutrien

     

    Non-

    Controlling

    Interest

     

     

    Total

    Equity

    Balance – December 31, 2023

    494,551,730

     

    13,838

     

    83

     

    (286)

     

    (10)

     

    (296)

     

    11,531

     

    25,156

     

    45

     

     

    25,201

    Net earnings

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    561

     

    561

     

    21

     

     

    582

    Other comprehensive income

    ‐

     

    ‐

     

    ‐

     

    28

     

    36

     

    64

     

    ‐

     

    64

     

    ‐

     

     

    64

    Shares repurchased for cancellation (Note 8)

    (1,039,185)

     

    (29)

     

    (21)

     

    ‐

     

    ‐

     

    ‐

     

    (1)

     

    (51)

     

    ‐

     

     

    (51)

    Dividends declared 1

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (800)

     

    (800)

     

    ‐

     

     

    (800)

    Non-controlling interest transactions

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (26)

     

     

    (26)

    Effect of share-based compensation including issuance of common shares

    369,904

     

    18

     

    5

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    23

     

    ‐

     

     

    23

    Transfer of net loss on cash flow hedges

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    13

     

    13

     

    ‐

     

    13

     

    ‐

     

     

    13

    Balance – September 30, 2024

    493,882,449

     

    13,827

     

    67

     

    (258)

     

    39

     

    (219)

     

    11,291

     

    24,966

     

    40

     

     

    25,006

    Balance – December 31, 2024

    491,025,446

     

    13,748

     

    68

     

    (537)

     

    22

     

    (515)

     

    11,106

     

    24,407

     

    35

     

     

    24,442

    Net earnings

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    1,696

     

    1,696

     

    21

     

     

    1,717

    Other comprehensive income (loss)

    ‐

     

    ‐

     

    ‐

     

    195

     

    (5)

     

    190

     

    ‐

     

    190

     

    1

     

     

    191

    Shares repurchased for cancellation (Note 8)

    (7,288,910)

     

    (204)

     

    (11)

     

    ‐

     

    ‐

     

    ‐

     

    (194)

     

    (409)

     

    ‐

     

     

    (409)

    Dividends declared 1

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (797)

     

    (797)

     

    ‐

     

     

    (797)

    Non-controlling interest transactions

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (21)

     

     

    (21)

    Effect of share-based compensation including issuance of common shares

    593,873

     

    36

     

    (1)

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    35

     

    ‐

     

     

    35

    Transfer of net gain on sale of investment

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (27)

     

    (27)

     

    27

     

    ‐

     

    ‐

     

     

    ‐

    Transfer of net gain on cash flow hedges

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (6)

     

    (6)

     

    ‐

     

    (6)

     

    ‐

     

     

    (6)

    Other

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    1

     

    1

     

    ‐

     

     

    1

    Balance – September 30, 2025

    484,330,409

     

    13,580

     

    56

     

    (342)

     

    (16)

     

    (358)

     

    11,839

     

    25,117

     

    36

     

     

    25,153

    1 During the nine months ended September 30, 2025, we declared dividends of $1.64 per share (2024 - $1.62 per share).

       

    (See Notes to the Condensed Consolidated Financial Statements)

       
       

    Condensed Consolidated Balance Sheets

     

     

     

     

     

     

    As at

     

     

    As at September 30

     

    December 31,

    ($ millions)

    Note

    2025

     

    2024

     

    2024

    Assets

     

     

     

     

     

     

    Current assets

     

     

     

     

     

     

    Cash and cash equivalents

     

    624

     

    520

     

    853

    Receivables

    9

    7,687

     

    7,786

     

    5,390

    Inventories

     

    5,281

     

    4,890

     

    6,148

    Prepaid expenses and other current assets

     

    598

     

    678

     

    1,401

    Assets held for sale

    5

    284

     

    ‐

     

    ‐

     

     

    14,474

     

    13,874

     

    13,792

    Non-current assets

     

     

     

     

     

     

    Property, plant and equipment

     

    22,480

     

    22,329

     

    22,604

    Goodwill

     

    12,116

     

    12,122

     

    12,043

    Intangible assets

     

    1,711

     

    1,877

     

    1,819

    Investments

    5

    142

     

    739

     

    698

    Other assets

     

    903

     

    970

     

    884

    Total Assets

     

    51,826

     

    51,911

     

    51,840

    Liabilities

     

     

     

     

     

     

    Current liabilities

     

     

     

     

     

     

    Short-term debt

     

    2,486

     

    2,967

     

    1,534

    Current portion of long-term debt

    7

    538

     

    1,013

     

    1,037

    Current portion of lease liabilities

     

    350

     

    364

     

    356

    Payables and accrued charges

    9

    6,899

     

    6,613

     

    9,118

     

     

    10,273

     

    10,957

     

    12,045

    Non-current liabilities

     

     

     

     

     

     

    Long-term debt

    7

    9,852

     

    9,383

     

    8,881

    Lease liabilities

     

    954

     

    1,029

     

    999

    Deferred income tax liabilities

     

    3,678

     

    3,555

     

    3,539

    Pension and other post-retirement benefit liabilities

     

    229

     

    245

     

    227

    Asset retirement obligations and accrued environmental costs

     

    1,440

     

    1,564

     

    1,543

    Other non-current liabilities

     

    247

     

    172

     

    164

    Total Liabilities

     

    26,673

     

    26,905

     

    27,398

    Shareholders' Equity

     

     

     

     

     

     

    Share capital

    8

    13,580

     

    13,827

     

    13,748

    Contributed surplus

     

    56

     

    67

     

    68

    Accumulated other comprehensive loss

     

    (358)

     

    (219)

     

    (515)

    Retained earnings

     

    11,839

     

    11,291

     

    11,106

    Equity holders of Nutrien

     

    25,117

     

    24,966

     

    24,407

    Non-controlling interest

     

    36

     

    40

     

    35

    Total Shareholders' Equity

     

    25,153

     

    25,006

     

    24,442

    Total Liabilities and Shareholders' Equity

     

    51,826

     

    51,911

     

    51,840

     

     

     

     

     

     

     

    (See Notes to the Condensed Consolidated Financial Statements)

     

    Notes to the Condensed Consolidated Financial Statements

    As at and for the Three and Nine Months Ended September 30, 2025

    Note 1 Basis of presentation

    Nutrien Ltd. (collectively with its subsidiaries, "Nutrien", "we", "us", "our" or "the Company") is a leading global provider of crop inputs and services. We operate a world-class network of production, distribution and ag retail facilities that positions us to efficiently serve the needs of farmers.

    These unaudited interim condensed consolidated financial statements ("interim financial statements") are based on International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board and have been prepared in accordance with IAS 34, "Interim Financial Reporting". The accounting policies and methods of computation used in preparing these interim financial statements are materially consistent with those used in the preparation of our 2024 annual audited consolidated financial statements. These interim financial statements include the accounts of Nutrien and its subsidiaries; however, they do not include all disclosures normally provided in annual audited consolidated financial statements and should be read in conjunction with our 2024 annual audited consolidated financial statements. These interim financial statements are presented in millions of US dollars, unless otherwise indicated, which is the functional currency of Nutrien and the majority of its subsidiaries.

    Certain immaterial 2024 figures have been reclassified in the condensed consolidated statements of cash flows.

    In management's opinion, the interim financial statements include all adjustments necessary to fairly present such information in all material respects. Interim results are not necessarily indicative of the results expected for any other interim period or the fiscal year. These interim financial statements were authorized for issue by the Audit Committee of the Board of Directors on November 5, 2025.

    Note 2 Segment information

    We have four reportable operating segments: Nutrien Ag Solutions ("Retail"), Potash, Nitrogen and Phosphate. Our downstream Retail segment distributes crop nutrients, crop protection products, seed and merchandise, and provides agronomic application services and solutions, including the services offered through Nutrien Financial. Retail also manufactures and distributes proprietary products and provides services directly to farmers through a network of retail locations in North America, South America and Australia. Our upstream Potash, Nitrogen and Phosphate segments are differentiated by the chemical nutrient contained in the products that each segment produces and are supported by midstream activities, which include the global sales, freight, transportation and distribution of our products, which are reported within these segments, respectively. Potash freight, transportation and distribution costs only apply to our North American potash sales volumes. Sales reported under our Corporate and Others segment relates to our non-core business. EBITDA presented in the succeeding tables is calculated as net earnings (loss) before finance costs, income taxes, and depreciation and amortization.

    Seasonality in our business results from increased demand for products during planting season. Crop input sales are generally higher in the spring and fall application seasons. Crop input inventories are normally accumulated leading up to each application season. Our cash collections generally occur after the application season is complete, while customer prepayments received are typically concentrated in December and January and inventory prepayments paid to our suppliers are typically concentrated in the period from November to January. Feed and industrial sales are more evenly distributed throughout the year.

     

    Downstream

     

    Upstream and Midstream

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Corporate

     

     

     

     

    ($ millions)

    Retail

     

    Potash

     

    Nitrogen

     

    Phosphate

     

    and Others

     

    Eliminations

     

    Consolidated

    Assets – as at September 30, 2025

    22,535

     

    13,837

     

    11,269

     

    2,535

     

    2,246

     

    (596)

     

    51,826

    Assets – as at December 31, 2024

    22,149

     

    13,792

     

    11,603

     

    2,453

     

    2,571

     

    (728)

     

    51,840

     

     

     

    Three Months Ended September 30, 2025

     

     

    Downstream

     

    Upstream and Midstream

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Corporate

     

     

     

     

    ($ millions)

    Retail

     

    Potash

     

    Nitrogen

     

    Phosphate

     

    and Others

     

    Eliminations

     

    Consolidated

    Sales

    – third party

    3,415

     

    1,127

     

    1,000

     

    462

     

    3

     

    ‐

     

    6,007

     

    – intersegment

    12

     

    130

     

    195

     

    99

     

    ‐

     

    (436)

     

    ‐

    Sales

    – total

    3,427

     

    1,257

     

    1,195

     

    561

     

    3

     

    (436)

     

    6,007

    Freight, transportation and distribution

    ‐

     

    135

     

    132

     

    66

     

    ‐

     

    (61)

     

    272

    Net sales

    3,427

     

    1,122

     

    1,063

     

    495

     

    3

     

    (375)

     

    5,735

    Cost of goods sold

    2,505

     

    437

     

    666

     

    436

     

    2

     

    (275)

     

    3,771

    Gross margin

    922

     

    685

     

    397

     

    59

     

    1

     

    (100)

     

    1,964

    Selling expenses (recovery)

    792

     

    3

     

    7

     

    2

     

    (2)

     

    (7)

     

    795

    General and administrative expenses

    44

     

    3

     

    4

     

    2

     

    91

     

    ‐

     

    144

    Provincial mining taxes

    ‐

     

    124

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    124

    Share-based compensation expense

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    28

     

    ‐

     

    28

    Foreign exchange gain, net of related derivatives

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (11)

     

    ‐

     

    (11)

    Other expenses (income)

    40

     

    10

     

    (13)

     

    5

     

    32

     

    3

     

    77

    Earnings (loss) before finance costs and income taxes

    46

     

    545

     

    399

     

    50

     

    (137)

     

    (96)

     

    807

    Depreciation and amortization

    184

     

    188

     

    157

     

    72

     

    16

     

    ‐

     

    617

    EBITDA

    230

     

    733

     

    556

     

    122

     

    (121)

     

    (96)

     

    1,424

    Share-based compensation expense

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    28

     

    ‐

     

    28

    ARO/ERL related income for non-operating sites

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (10)

     

    ‐

     

    (10)

    Foreign exchange gain, net of related derivatives

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (11)

     

    ‐

     

    (11)

    Adjusted EBITDA

    230

     

    733

     

    556

     

    122

     

    (114)

     

    (96)

     

    1,431

     

     

     

    Three Months Ended September 30, 2024

     

     

    Downstream

     

    Upstream and Midstream

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Corporate

     

     

     

     

    ($ millions)

    Retail

     

    Potash

     

    Nitrogen

     

    Phosphate

     

    and Others

     

    Eliminations

     

    Consolidated

    Sales

    – third party

    3,271

     

    915

     

    753

     

    409

     

    ‐

     

    ‐

     

    5,348

     

    – intersegment

    ‐

     

    113

     

    163

     

    58

     

    ‐

     

    (334)

     

    ‐

    Sales

    – total

    3,271

     

    1,028

     

    916

     

    467

     

    ‐

     

    (334)

     

    5,348

    Freight, transportation and distribution

    ‐

     

    144

     

    123

     

    55

     

    ‐

     

    (59)

     

    263

    Net sales

    3,271

     

    884

     

    793

     

    412

     

    ‐

     

    (275)

     

    5,085

    Cost of goods sold

    2,412

     

    422

     

    581

     

    383

     

    ‐

     

    (213)

     

    3,585

    Gross margin

    859

     

    462

     

    212

     

    29

     

    ‐

     

    (62)

     

    1,500

    Selling expenses (recovery)

    815

     

    3

     

    8

     

    1

     

    (2)

     

    (5)

     

    820

    General and administrative expenses

    51

     

    5

     

    6

     

    4

     

    90

     

    ‐

     

    156

    Provincial mining taxes

    ‐

     

    74

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    74

    Share-based compensation expense

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    1

     

    ‐

     

    1

    Foreign exchange loss, net of related derivatives

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    31

     

    ‐

     

    31

    Other expenses (income)

    32

     

    2

     

    (25)

     

    10

     

    194

     

    9

     

    222

    Earnings (loss) before finance costs and income taxes

    (39)

     

    378

     

    223

     

    14

     

    (314)

     

    (66)

     

    196

    Depreciation and amortization

    190

     

    177

     

    132

     

    75

     

    24

     

    ‐

     

    598

    EBITDA

    151

     

    555

     

    355

     

    89

     

    (290)

     

    (66)

     

    794

    Share-based compensation expense

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    1

     

    ‐

     

    1

    ARO/ERL related expenses for non-operating sites

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    184

     

    ‐

     

    184

    Foreign exchange loss, net of related derivatives

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    31

     

    ‐

     

    31

    Adjusted EBITDA

    151

     

    555

     

    355

     

    89

     

    (74)

     

    (66)

     

    1,010

     

     

     

    Nine Months Ended September 30, 2025

     

     

    Downstream

     

    Upstream and Midstream

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Corporate

     

     

     

     

    ($ millions)

    Retail

     

    Potash

     

    Nitrogen

     

    Phosphate

     

    and Others

     

    Eliminations

     

    Consolidated

    Sales

    – third party

    14,464

     

    2,885

     

    2,996

     

    1,182

     

    18

     

    ‐

     

    21,545

     

    – intersegment

    12

     

    318

     

    686

     

    233

     

    ‐

     

    (1,249)

     

    ‐

    Sales

    – total

    14,476

     

    3,203

     

    3,682

     

    1,415

     

    18

     

    (1,249)

     

    21,545

    Freight, transportation and distribution

    ‐

     

    346

     

    405

     

    164

     

    ‐

     

    (177)

     

    738

    Net sales

    14,476

     

    2,857

     

    3,277

     

    1,251

     

    18

     

    (1,072)

     

    20,807

    Cost of goods sold

    10,850

     

    1,257

     

    2,073

     

    1,160

     

    6

     

    (998)

     

    14,348

    Gross margin

    3,626

     

    1,600

     

    1,204

     

    91

     

    12

     

    (74)

     

    6,459

    Selling expenses (recovery)

    2,495

     

    8

     

    22

     

    5

     

    (7)

     

    (20)

     

    2,503

    General and administrative expenses

    132

     

    7

     

    16

     

    5

     

    284

     

    ‐

     

    444

    Provincial mining taxes

    ‐

     

    289

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    289

    Share-based compensation expense

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    119

     

    ‐

     

    119

    Foreign exchange loss, net of related derivatives

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    18

     

    ‐

     

    18

    Other expenses

    119

     

    20

     

    ‐

     

    18

     

    96

     

    18

     

    271

    Earnings (loss) before finance costs and income taxes

    880

     

    1,276

     

    1,166

     

    63

     

    (498)

     

    (72)

     

    2,815

    Depreciation and amortization

    545

     

    533

     

    465

     

    212

     

    47

     

    ‐

     

    1,802

    EBITDA

    1,425

     

    1,809

     

    1,631

     

    275

     

    (451)

     

    (72)

     

    4,617

    Restructuring costs

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    22

     

    ‐

     

    22

    Share-based compensation expense

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    119

     

    ‐

     

    119

    ARO/ERL related income for non-operating sites

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (7)

     

    ‐

     

    (7)

    Foreign exchange loss, net of related derivatives

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    18

     

    ‐

     

    18

    Adjusted EBITDA

    1,425

     

    1,809

     

    1,631

     

    275

     

    (299)

     

    (72)

     

    4,769

     

     

     

    Nine Months Ended September 30, 2024

     

     

    Downstream

     

    Upstream and Midstream

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Corporate

     

     

     

     

    ($ millions)

    Retail

     

    Potash

     

    Nitrogen

     

    Phosphate

     

    and Others

     

    Eliminations

     

    Consolidated

    Sales

    – third party

    14,653

     

    2,486

     

    2,547

     

    1,207

     

    ‐

     

    ‐

     

    20,893

     

    – intersegment

    ‐

     

    305

     

    584

     

    210

     

    ‐

     

    (1,099)

     

    ‐

    Sales

    – total

    14,653

     

    2,791

     

    3,131

     

    1,417

     

    ‐

     

    (1,099)

     

    20,893

    Freight, transportation and distribution

    ‐

     

    338

     

    399

     

    174

     

    ‐

     

    (170)

     

    741

    Net sales

    14,653

     

    2,453

     

    2,732

     

    1,243

     

    ‐

     

    (929)

     

    20,152

    Cost of goods sold

    11,018

     

    1,139

     

    1,835

     

    1,116

     

    ‐

     

    (905)

     

    14,203

    Gross margin

    3,635

     

    1,314

     

    897

     

    127

     

    ‐

     

    (24)

     

    5,949

    Selling expenses (recovery)

    2,610

     

    9

     

    23

     

    5

     

    (7)

     

    (18)

     

    2,622

    General and administrative expenses

    154

     

    10

     

    16

     

    11

     

    277

     

    ‐

     

    468

    Provincial mining taxes

    ‐

     

    210

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    210

    Share-based compensation expense

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    17

     

    ‐

     

    17

    Impairment of assets

    335

     

    ‐

     

    195

     

    ‐

     

    ‐

     

    ‐

     

    530

    Foreign exchange loss, net of related derivatives

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    359

     

    ‐

     

    359

    Other expenses (income)

    95

     

    3

     

    (136)

     

    26

     

    274

     

    22

     

    284

    Earnings (loss) before finance costs and income taxes

    441

     

    1,082

     

    799

     

    85

     

    (920)

     

    (28)

     

    1,459

    Depreciation and amortization

    580

     

    475

     

    419

     

    213

     

    62

     

    ‐

     

    1,749

    EBITDA

    1,021

     

    1,557

     

    1,218

     

    298

     

    (858)

     

    (28)

     

    3,208

    Share-based compensation expense

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    17

     

    ‐

     

    17

    Impairment of assets

    335

     

    ‐

     

    195

     

    ‐

     

    ‐

     

    ‐

     

    530

    Loss related to financial instruments in Argentina

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    34

     

    ‐

     

    34

    ARO/ERL related expenses for non-operating sites

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    152

     

    ‐

     

    152

    Foreign exchange loss, net of related derivatives

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    359

     

    ‐

     

    359

    Adjusted EBITDA

    1,356

     

    1,557

     

    1,413

     

    298

     

    (296)

     

    (28)

     

    4,300

     

     

    Three Months Ended

     

    Nine Months Ended

     

    September 30

     

    September 30

    ($ millions)

    2025

     

    2024

     

    2025

     

    2024

    Retail sales by product line

     

     

     

     

     

     

     

    Crop nutrients

    1,188

     

    1,093

     

    5,773

     

    5,683

    Crop protection products

    1,536

     

    1,518

     

    5,174

     

    5,365

    Seed

    156

     

    132

     

    1,966

     

    2,051

    Services and other

    258

     

    242

     

    690

     

    690

    Merchandise

    222

     

    222

     

    649

     

    667

    Nutrien Financial

    89

     

    85

     

    294

     

    284

    Nutrien Financial elimination 1

    (22)

     

    (21)

     

    (70)

     

    (87)

     

    3,427

     

    3,271

     

    14,476

     

    14,653

    Potash sales by geography

     

     

     

     

     

     

     

    Manufactured product

     

     

     

     

     

     

     

    North America

    633

     

    601

     

    1,449

     

    1,474

    Offshore 2

    623

     

    427

     

    1,750

     

    1,316

    Other potash and purchased products

    1

     

    ‐

     

    4

     

    1

     

    1,257

     

    1,028

     

    3,203

     

    2,791

    Nitrogen sales by product line

     

     

     

     

     

     

     

    Manufactured product

     

     

     

     

     

     

     

    Ammonia

    300

     

    261

     

    899

     

    856

    Urea and ESN®

    376

     

    293

     

    1,288

     

    1,085

    Solutions, nitrates and sulfates

    466

     

    299

     

    1,217

     

    961

    Other nitrogen and purchased products

    53

     

    63

     

    278

     

    229

     

    1,195

     

    916

     

    3,682

     

    3,131

    Phosphate sales by product line

     

     

     

     

     

     

     

    Manufactured product

     

     

     

     

     

     

     

    Fertilizer

    379

     

    316

     

    913

     

    928

    Industrial and feed

    178

     

    148

     

    484

     

    470

    Other phosphate and purchased products

    4

     

    3

     

    18

     

    19

     

    561

     

    467

     

    1,415

     

    1,417

    1 Represents elimination of the interest and service fees charged by Nutrien Financial to Retail branches.

    2 Relates to Canpotex Limited ("Canpotex") (see Note 9) and includes provisional pricing adjustments for the three months ended September 30, 2025 of $(13) million (2024 – $(4) million) and the nine months ended September 30, 2025 of $45 million (2024 – $7 million).

     

    Note 3 Other expenses (income)

     

    Three Months Ended

     

    Nine Months Ended

     

    September 30

     

    September 30

    ($ millions)

    2025

     

    2024

     

    2025

     

    2024

    Restructuring costs

    ‐

     

    ‐

     

    22

     

    ‐

    Earnings of equity-accounted investees

    (22)

     

    (26)

     

    (36)

     

    (107)

    Bad debt expense

    31

     

    31

     

    88

     

    94

    Project feasibility costs

    28

     

    19

     

    69

     

    62

    Customer prepayment costs

    13

     

    10

     

    50

     

    41

    Legal expenses

    6

     

    4

     

    13

     

    12

    Insurance recoveries

    (1)

     

    (3)

     

    (1)

     

    (70)

    Loss on natural gas derivatives not designated as a hedge

    ‐

     

    5

     

    ‐

     

    7

    Loss related to financial instruments in Argentina

    ‐

     

    ‐

     

    ‐

     

    34

    ARO/ERL related (income) expenses for non-operating sites ¹

    (10)

     

    184

     

    (7)

     

    152

    Other expenses (income)

    32

     

    (2)

     

    73

     

    59

     

    77

     

    222

     

    271

     

    284

    1 ARO/ERL refers to asset retirement obligations and accrued environmental costs.

     

    Note 4 Income taxes

    A separate estimated average annual effective income tax rate was determined and applied individually to the interim period pre-tax earnings for each taxing jurisdiction.

     

    Three Months Ended

     

    Nine Months Ended

     

    September 30

     

    September 30

    ($ millions, except as otherwise noted)

    2025

     

    2024

     

    2025

     

    2024

    Actual effective tax rate on earnings (%)

    27

     

    (18)

     

    25

     

    41

    Actual effective tax rate including discrete items (%)

    26

     

    (112)

     

    26

     

    38

    Discrete tax adjustments that impacted the tax rate 1

    (4)

     

    (11)

     

    23

     

    (31)

    1 Discrete tax adjustments arise from specific, significant or unusual events that are recognized in the period in which the event occurs, rather than being allocated across the year through the annual effective tax rate.

     

    Note 5 Investments

     

     

     

     

     

     

    Proportion of

    Ownership Interest and

     

     

     

     

     

     

     

    Principal

     

    Voting Rights Held (%)

     

    Carrying Amount

     

     

     

     

    Place of

     

    As at

    As at

     

    As at

    As at

    ($ millions, except as otherwise noted)

     

    Principal

     

    Business and

     

    September 30,

    December 31,

     

    September 30,

    December 31,

    Activity

     

    Incorporation

     

    2025

    2024

     

    2025

    2024

    Equity-accounted investees

     

     

     

     

     

     

     

     

    Profertil S.A. ("Profertil")

    Nitrogen producer

     

    Argentina

     

    50

    50

     

    ‐

    349

    Canpotex

     

    Marketing and logistics of potash

     

    Canada

     

    50

    50

     

    ‐

    ‐

    Other associates and joint ventures

     

     

     

     

     

     

    132

    128

    Total equity-accounted investees

     

     

     

     

     

     

    132

    477

    Investments at FVTOCI

     

     

     

     

     

    Sinofert Holdings Limited ("Sinofert")

     

    Fertilizer supplier and distributor

     

    China/Bermuda

     

    ‐

    22

     

    ‐

    211

    Other

     

     

     

     

     

     

     

     

    10

    10

    Total investments at FVTOCI

     

     

     

     

     

     

    10

    221

    Total investments

     

     

     

     

     

     

    142

    698

     

    Investments at fair value through other comprehensive income

    During the three months ended March 31, 2025, we fully divested our remaining equity ownership interest in Sinofert, which had been classified as a financial asset measured at fair value through other comprehensive income. Total proceeds from the sale were $193 million and reflected the fair value of the investment at the date of derecognition. A fair value loss of $18 million related to the investment was recognized in the period in other comprehensive income. Upon derecognition, the cumulative unrealized gain previously recognized in other comprehensive income of $27 million was reclassified to retained earnings.

    Equity-accounted investees

    During the three months ended September 30, 2025, as part of our portfolio review, we entered into an agreement to sell our 50 percent equity ownership in Profertil, which had been classified as an equity-accounted investment. As at September 30, 2025, we have reclassified the investment, with a net book value totaling $284 million, to a current asset held for sale under our Corporate and Others segment. A deposit of $120 million was received from the purchaser on September 5, 2025. Gross proceeds from the sale are expected to be approximately $600 million and the transaction is expected to close in the fourth quarter of 2025, subject to the exercise of a right of first refusal by the remaining joint venture partner.

    Note 6 Financial instruments

    Foreign currency derivatives

     

    Three Months Ended

     

    Nine Months Ended

     

    September 30

     

    September 30

    ($ millions)

    2025

     

    2024

     

    2025

     

    2024

    Foreign exchange (gain) loss

    (26)

     

    (3)

     

    (9)

     

    27

    Hyperinflationary loss

    ‐

     

    20

     

    ‐

     

    85

    Loss on foreign currency derivatives at fair value through profit or loss

    15

     

    14

     

    27

     

    247

    Foreign exchange (gain) loss, net of related derivatives

    (11)

     

    31

     

    18

     

    359

     

    Our financial instruments carrying amount are a reasonable approximation of their fair values, except for our long-term debt, including current portion, that has a carrying value of $10,390 million and fair value of $10,027 million as at September 30, 2025. There were no transfers between levels for financial instruments measured at fair value on a recurring basis.

    Note 7 Debt

    During the three months ended September 30, 2025, we extended the maturity of our $4,500 million unsecured committed revolving term facility to September 4, 2030. We also extended the term of our unsecured committed revolving term credit facility to September 2, 2026 and reduced the facility limit from $750 million to $500 million.

    ($ millions, except as otherwise noted)

    Rate of interest (%)

     

    Maturity

     

    Amount

    Senior notes repaid in 2025

    3.000

     

    April 1, 2025

     

    500

     

     

     

     

     

     

    Senior notes issued in 2025

    4.500

     

    March 12, 2027

     

    400

    Senior notes issued in 2025

    5.250

     

    March 12, 2032

     

    600

     

     

     

     

     

    1,000

    The senior notes issued in the nine months ended September 30, 2025, are unsecured, rank equally with our existing unsecured debt, and have no sinking fund requirements prior to maturity. Each series of outstanding senior notes is redeemable and has various provisions for redemption prior to maturity, at our option, at specified prices.

    Note 8 Share capital

    Share repurchase programs

    The following table summarizes our share repurchase activities during the periods indicated below:

     

    Three Months Ended

     

    Nine Months Ended

     

    September 30

     

    September 30

    ($ millions, except as otherwise noted)

    2025

     

    2024

     

    2025

     

    2024

    Number of common shares repurchased for cancellation

    2,547,124

     

    1,039,185

     

    7,288,910

     

    1,039,185

    Average price per share (US dollars)

    58.27

     

    48.11

     

    54.96

     

    48.11

    Total cost, inclusive of tax

    152

     

    51

     

    409

     

    51

    Subsequent to September 30, 2025, as of November 4, 2025, an additional 993,278 common shares were repurchased for cancellation at a cost of $56 million and an average price per share of $57.80.

    Dividends declared

    We declared a dividend per share of $0.545 (2024 – $0.54) during the three months ended September 30, 2025, payable on October 17, 2025 to shareholders of record on September 29, 2025.

    Note 9 Related party transactions

    We sell potash outside Canada and the US exclusively through Canpotex. Our total revenue is recognized at the amount received from Canpotex representing proceeds from their sale of potash, less net costs of Canpotex. The receivable outstanding from Canpotex arose from sale transactions described above. It is unsecured and bears no interest. Any credit losses held against this receivable are expected to be negligible. Canpotex sells potash to buyers, including Nutrien, in export markets pursuant to term and spot contracts at agreed-upon prices. Purchases from Canpotex for the three months ended September 30, 2025 were $23 million (2024– $41 million) and the nine months ended September 30, 2025 were $100 million (2024 – $112 million).

     

     

    As at

     

    As at

    ($ millions)

     

    September 30, 2025

     

    December 31, 2024

    Receivables from Canpotex

     

    208

     

    122

    Payables to Canpotex

     

    63

     

    66

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20251028876853/en/

    Investor Contact:

    Jeff Holzman

    Senior Vice President, Investor Relations and FP&A

    (306) 933-8545 – [email protected]

    Media Contact:

    Simon Scott

    Vice President, Global Communications

    (403) 225-7213 – [email protected]

    Get the next $NTR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NTR

    DatePrice TargetRatingAnalyst
    11/11/2025$64.00Equal Weight
    Wells Fargo
    10/14/2025$67.00Buy → Neutral
    BofA Securities
    9/5/2025Sector Perform
    National Bank Financial
    7/11/2025$66.00Buy → Hold
    Jefferies
    6/17/2025$68.00Outperform → Mkt Perform
    Raymond James
    5/14/2025$62.00Sector Outperform → Sector Perform
    Scotiabank
    3/13/2025$53.00Sell
    Goldman
    1/21/2025$55.00 → $56.00Overweight → Equal Weight
    Barclays
    More analyst ratings

    $NTR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Nutrien Completes Sale of Equity Position in Profertil S.A.

    Nutrien Ltd. (TSX and NYSE:NTR) announced today that it has completed the sale of its 50 percent equity position in Argentina-based nitrogen producer Profertil S.A. (Profertil) to Adecoagro S.A. and Asociacion de Cooperativas Argentinas Coop Ltda through a joint acquisition. Total proceeds from the sale on a pre-tax basis are approximately US$600 million. "Closing the sale of our equity stake in Profertil demonstrates continued progress towards simplifying our portfolio, enhancing earnings quality, and improving cash conversion," said Ken Seitz, Nutrien's President and CEO. "We intend to allocate the proceeds towards capital allocation priorities that support our ability to grow free cash

    12/10/25 4:15:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    Nutrien Declares Quarterly Dividend of US$0.545 per Share

    Nutrien Ltd. (TSX and NYSE:NTR) announced today that its Board of Directors has declared a quarterly dividend of US$0.545 per share payable on January 16, 2026, to shareholders of record on December 31, 2025. Registered shareholders who are residents of Canada as reflected in Nutrien's shareholders register, as well as beneficial holders (i.e., shareholders who hold their common shares through a broker or other intermediary) whose intermediary is a participant in CDS Clearing and Depositary Services Inc. or its nominee, CDS & Co., will receive their dividend in Canadian dollars, calculated based on the Bank of Canada daily average exchange rate on December 31, 2025. Registered shareholders

    11/5/25 5:05:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    Nutrien Reports Third Quarter 2025 Results

    Nine-month results supported by strong operational performance and continue to show progress towards our 2026 targets. Initiating a review of strategic alternatives for our Phosphate business to enhance long-term value. All amounts are in US dollars, except as otherwise noted Nutrien Ltd. (TSX and NYSE:NTR) announced today its third quarter 2025 results, with net earnings of $0.5 billion ($0.96 diluted net earnings per share). Third quarter 2025 adjusted EBITDA1 was $1.4 billion and adjusted net earnings per share1 was $0.97. "Nutrien delivered structural earnings growth in the first nine months of 2025 through record upstream fertilizer sales volumes, improved reliability and high

    11/5/25 5:00:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    $NTR
    Leadership Updates

    Live Leadership Updates

    View All

    $NTR
    Financials

    Live finance-specific insights

    View All

    $NTR
    SEC Filings

    View All

    $NTR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Nutrien Announces Results of 2025 Annual Meeting

    Nutrien Ltd. (TSX and NYSE:NTR) announced today the results of its annual meeting of shareholders held on May 7, 2025 (the "Meeting"). A total of 488,556,988 common shares, representing 74.48% of common shares outstanding, were represented at the Meeting. Results of the matters voted on at the Meeting are set out below. Election of Directors Nutrien's 12 director nominees were elected: Votes For (percent) Votes Against (percent) Christopher M. Burley 98.02% 1.98% Maura J. Clark 98.88% 1.12% Russell K. Girling 96.64% 3.36% Michael J. Hennigan 96.21% 3.79% Miranda C. Hubbs 98.20% 1.80% Raj S. Kushwaha 98.88% 1.12%

    5/7/25 8:31:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    Nutrien Announces Results of 2024 Annual Meeting

    Nutrien Ltd. (NYSE:NTR) announced today the results of its annual meeting of shareholders held on May 8, 2024 (the "Meeting"). A total of 369,251,444 common shares, representing 74.66% of common shares outstanding, were represented at the Meeting. Results of the matters voted on at the Meeting are set out below. Election of Directors Nutrien's 12 director nominees were elected: Votes For (percent) Votes Against (percent) Christopher M. Burley 98.33% 1.67% Maura J. Clark 98.95% 1.05% Russell K. Girling 98.31% 1.69% Michael J. Hennigan 94.88% 5.12% Miranda C. Hubbs 98.48% 1.52%

    5/8/24 7:11:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    Nutrien Announces Results of 2023 Annual Meeting

    Nutrien Ltd. (NYSE:NTR) announced today the results of its annual meeting of shareholders held on May 10, 2023 (the "Meeting"). A total of 386,934,221 common shares, representing 77.42% of common shares outstanding, were represented at the Meeting. Results of the matters voted on at the Meeting are set out below. Election of Directors Nutrien's 12 director nominees were elected: Votes For (percent) Votes Against (percent) Christopher M. Burley 95.86% 4.14% Maura J. Clark 95.57% 4.43% Russell K. Girling 93.30% 6.70% Michael J. Hennigan 91.15% 8.85% Miranda C. Hubbs 95.80% 4.20

    5/10/23 7:44:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    Nutrien Declares Quarterly Dividend of US$0.545 per Share

    Nutrien Ltd. (TSX and NYSE:NTR) announced today that its Board of Directors has declared a quarterly dividend of US$0.545 per share payable on January 16, 2026, to shareholders of record on December 31, 2025. Registered shareholders who are residents of Canada as reflected in Nutrien's shareholders register, as well as beneficial holders (i.e., shareholders who hold their common shares through a broker or other intermediary) whose intermediary is a participant in CDS Clearing and Depositary Services Inc. or its nominee, CDS & Co., will receive their dividend in Canadian dollars, calculated based on the Bank of Canada daily average exchange rate on December 31, 2025. Registered shareholders

    11/5/25 5:05:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    Nutrien Reports Third Quarter 2025 Results

    Nine-month results supported by strong operational performance and continue to show progress towards our 2026 targets. Initiating a review of strategic alternatives for our Phosphate business to enhance long-term value. All amounts are in US dollars, except as otherwise noted Nutrien Ltd. (TSX and NYSE:NTR) announced today its third quarter 2025 results, with net earnings of $0.5 billion ($0.96 diluted net earnings per share). Third quarter 2025 adjusted EBITDA1 was $1.4 billion and adjusted net earnings per share1 was $0.97. "Nutrien delivered structural earnings growth in the first nine months of 2025 through record upstream fertilizer sales volumes, improved reliability and high

    11/5/25 5:00:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    Nutrien Announces Release Dates for Third Quarter 2025 Results and Conference Call

    Nutrien Ltd. (TSX and NYSE:NTR) announced today plans to release third quarter 2025 results after market close on Wednesday, November 5. Nutrien will host a conference call to discuss its results and outlook at 10:00 a.m. EST on Thursday, November 6. Investors can access the call by dialing 1-800-990-2777 or 1-416-855-9085 and using conference ID: 26207. A webcast of the call can be accessed by visiting Nutrien's Investor Events and Presentation page. A recording of the call will be available after its completion and can be accessed at: www.nutrien.com/investors/events. The webcast link will be live for 12 months following the call. About Nutrien Nutrien is a leading global provider

    10/6/25 6:00:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    SEC Form 6-K filed by Nutrien Ltd.

    6-K - Nutrien Ltd. (0001725964) (Filer)

    12/10/25 4:30:14 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    SEC Form 6-K filed by Nutrien Ltd.

    6-K - Nutrien Ltd. (0001725964) (Filer)

    10/21/25 9:50:05 AM ET
    $NTR
    Agricultural Chemicals
    Industrials

    SEC Form 6-K filed by Nutrien Ltd.

    6-K - Nutrien Ltd. (0001725964) (Filer)

    9/8/25 7:28:02 AM ET
    $NTR
    Agricultural Chemicals
    Industrials

    Wells Fargo resumed coverage on Nutrien with a new price target

    Wells Fargo resumed coverage of Nutrien with a rating of Equal Weight and set a new price target of $64.00

    11/11/25 8:06:04 AM ET
    $NTR
    Agricultural Chemicals
    Industrials

    Nutrien downgraded by BofA Securities with a new price target

    BofA Securities downgraded Nutrien from Buy to Neutral and set a new price target of $67.00

    10/14/25 8:42:17 AM ET
    $NTR
    Agricultural Chemicals
    Industrials

    National Bank Financial initiated coverage on Nutrien

    National Bank Financial initiated coverage of Nutrien with a rating of Sector Perform

    9/5/25 11:14:06 AM ET
    $NTR
    Agricultural Chemicals
    Industrials